Restless leg syndrome

G6_RLS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — G25.8 Hospital discharge: ICD-10 — G25.8 Cause of death: ICD-10 — G25.8 3 out of 7 registries used, show all original rules.	5708
4. Check minimum number of events None	5708
5. Include endpoints None	5708
6. Filter based on genotype QC (FinnGen only)	5505

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF10

NAME	G6_RLS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	G258
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G258
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G258
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Restless leg syndrome based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	22541	14134	8331
Only index persons	21977	13876	8101
Unadjusted period prevalence (%)
Whole population	0.34	0.40	0.23
Only index persons	0.44	0.51	0.31
Median age at first event (years)
Whole population	64.52	65.47	63.04
Only index persons	64.47	65.40	62.88

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5505	3691	1814
Unadjusted period prevalence (%)	1.15	1.31	0.83
Median age at first event (years)	62.58	61.49	64.80

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5708: Matched controls
57080

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G47.3

ICD-10 Finland

Sleep apnoea

3.1

321.1

1891

7885

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

8.1

307.7

614

838

F51.0

ICD-10 Finland

Nonorganic insomnia

3.5

307.7

1560

5532

N04BC05

ATC

pramipexole; oral

64.7

307.7

3994

1983

N04BC04

ATC

ropinirole; oral

17.3

307.7

319

195

N02BF01

ATC

gabapentin; oral

4.6

307.7

1017

2591

N04

ICPC

Restless legs

58.8

307.7

317

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

307.7

5708

N03AX12

ATC

[U] gabapentin; oral

3.7

307.7

1731

5969

N03AX16

ATC

[U] pregabalin

3.2

307.7

2137

9026

N06AX11

ATC

mirtazapine; oral

3.0

307.7

2825

13944

N05AH04

ATC

quetiapine; oral

3.1

283.5

1532

6025

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

94.3

281.9

147

N03AE01

ATC

clonazepam; systemic

4.6

272.1

702

1676

N02BF02

ATC

pregabalin; oral

4.3

228.5

653

1680

N06AX21

ATC

duloxetine; oral

3.1

219.3

1096

4064

N05CF01

ATC

zopiclone; oral

2.4

203.1

2335

12978

M79.6

ICD-10 Finland

Pain in limb

2.3

195.4

2925

18074

N05BA04

ATC

oxazepam; oral

2.3

180.8

1920

10207

N06AX16

ATC

venlafaxine; oral

2.7

178.9

1162

4918

N04BC09

ATC

rotigotine; transdermal

19.1

175.4

138

N02AX02

ATC

tramadol; systemic, rectal

2.1

166.4

2842

18118

N05CF02

ATC

zolpidem; oral

2.5

164.1

1357

6421

M54.5

ICD-10 Finland

Low back pain

2.1

160.0

2451

14927

R53

ICD-10 Finland

Malaise and fatigue

2.3

160.0

1728

9168

P06

ICPC

Sleep disturbance

2.8

156.3

940

3804

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

9.5

155.9

186

201

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

145.8

2756

17952

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

60.8

140.1

N06AB04

ATC

citalopram; systemic

2.2

138.8

1510

7963

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

132.6

949

4161

N06AB10

ATC

escitalopram; oral

2.2

129.0

1411

7426

R06.0

ICD-10 Finland

Dyspnoea

2.1

128.8

1804

10434

N06AX12

ATC

bupropion; oral

3.1

126.9

565

1927

M03BX02

ATC

tizanidine; oral

2.0

118.8

3798

28770

L03

ICPC

Low back symptom/complaint

2.0

118.1

1867

11207

R03AC02

ATC

salbutamol; inhalant

1.9

116.5

3375

24678

L17

ICPC

Foot/toe symptom/complaint

2.0

115.8

1899

11530

C07AA05

ATC

propranolol; systemic

2.1

112.7

1379

7527

G47.9

ICD-10 Finland

Sleep disorder, unspecified

4.5

112.6

286

665

A02BC02

ATC

pantoprazole; systemic

2.0

110.3

4120

32445

N06AX26

ATC

vortioxetine; oral

2.9

110.2

558

2042

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

109.5

1743

10436

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

106.2

778

3425

A02BC05

ATC

esomeprazole; systemic

1.8

105.5

2559

17498

M25.5

ICD-10 Finland

Pain in joint

1.9

103.9

2071

13302

M79.1

ICD-10 Finland

Myalgia

2.2

103.3

1034

5201

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.0

101.4

1492

8657

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

99.7

1208

6533

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

98.8

635

2623

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

98.1

2723

19251

M01AH05

ATC

etoricoxib; oral

1.8

97.6

3685

28508

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

96.6

949

4727

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

93.3

2250

15193

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

4.8

92.7

216

468

N06AA09

ATC

amitriptyline; systemic

2.4

92.5

720

3247

N02BE01

ATC

paracetamol; systemic, rectal

2.6

91.9

5216

45851

R06.5

ICD-10 Finland

Mouth breathing

2.5

91.1

625

2659

R5140

NOMESCO Finland

Monitoring the use of the aid

2.4

90.0

728

3336

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.7

89.3

294

825

N06AB06

ATC

sertraline; oral

2.3

87.5

776

3696

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

84.9

1736

11089

R42

ICD-10 Finland

Dizziness and giddiness

1.9

84.0

1456

8834

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

3.8

81.2

254

688

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

79.3

713

3407

N06AX22

ATC

agomelatine; oral

4.2

78.7

213

519

N06AB03

ATC

fluoxetine; oral

2.1

78.4

825

4196

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.0

78.2

356

1222

G20

ICD-10 Finland

Parkinson disease

3.7

78.2

261

739

N06AX05

ATC

trazodone; oral

3.9

78.0

234

615

M48.0

ICD-10 Finland

Spinal stenosis

2.1

77.8

812

4116

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

77.7

411

1532

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.4

77.2

561

2444

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

76.3

1756

11539

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

76.0

1402

8633

G04BD12

ATC

mirabegron; oral

2.1

75.8

798

4056

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

75.7

799

4066

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

75.4

461

1850

R52.9

ICD-10 Finland

Pain, unspecified

2.2

74.5

669

3192

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

74.2

1696

11107

N05BA01

ATC

diazepam; systemic, rectal

2.1

73.5

842

4415

G25

ICD-10 Finland

Other extrapyramidal and movement disorders

25.7

73.2

R01AD09

ATC

mometasone; nasal

1.7

73.2

2669

19779

G44.2

ICD-10 Finland

Tension-type headache

2.0

72.8

910

4923

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

3.7

72.5

238

666

M79.7

ICD-10 Finland

Fibromyalgia

3.2

72.3

305

1001

L01

ICPC

Neck symptom/complaint

1.9

71.8

1011

5695

N05CD07

ATC

temazepam; oral

2.1

71.0

734

3699

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.3

70.9

613

2876

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

70.3

1647

10831

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

70.2

1525

9815

R51.80

ICD-10 Finland

Headache

1.9

69.8

990

5586

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

69.5

1732

11576

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

68.7

448

1852

M01AE02

ATC

naproxen; oral, rectal

1.6

68.6

3240

25450

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

68.4

633

3051

F32

ICD-10 Finland

Depressive episode

2.8

68.3

374

1418

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

67.4

2723

20550

M01AB05

ATC

diclofenac; systemic, rectal

1.7

67.0

3778

30921

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

66.1

1108

6588

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

65.9

1159

6992

N03AX09

ATC

lamotrigine; oral

2.8

65.8

338

1238

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

3.7

65.8

210

576

P76

ICPC

Depressive disorder

2.5

65.7

441

1848

R20.2

ICD-10 Finland

Paraesthesia of skin

2.4

65.1

485

2131

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

64.8

893

4980

N06AX03

ATC

mianserin; oral

2.8

64.4

348

1310

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

12.5

63.2

P03

ICPC

Feeling depressed

2.2

62.8

602

2939

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.2

62.8

557

2636

R35

ICD-10 Finland

Polyuria

2.5

62.7

438

1868

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

62.5

1361

8720

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

62.4

573

2749

J45

ICD-10 Finland

Asthma

2.1

61.4

675

3472

H02AB06

ATC

prednisolone; systemic

1.6

61.2

2717

20794

Z71.8

ICD-10 Finland

Other specified counselling

1.6

61.0

1780

12312

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

60.9

4035

33926

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

60.4

575

2798

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.7

59.7

345

1343

N05BA12

ATC

alprazolam; oral

2.1

59.5

648

3319

S18

ICPC

Laceration/cut

1.6

59.3

2582

19624

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.8

58.7

308

1141

A02BC01

ATC

omeprazole; systemic

1.7

58.4

1586

10751

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.9

58.1

872

4987

J01AA02

ATC

doxycycline; systemic

1.7

57.5

4410

38136

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

56.8

1366

8960

A04

ICPC

Weakness/tiredness general

1.9

56.2

890

5172

AA1AD

NOMESCO Finland

CT of head and brain

1.6

56.0

1550

10537

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

55.2

2554

19570

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

55.2

759

4213

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

54.5

2498

19083

P01

ICPC

Feeling anxious/nervous/tense

2.0

54.5

671

3586

N06AA06

ATC

trimipramine; systemic

3.4

53.9

197

591

WX723

NOMESCO Finland

CPAP therapy

2.9

53.8

269

970

R05

ICD-10 Finland

Cough

1.7

53.6

1264

8229

R25.2

ICD-10 Finland

Cramp and spasm

3.5

53.3

189

556

F51

ICD-10 Finland

Nonorganic sleep disorders

2.8

52.9

283

1058

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

52.6

2324

17567

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

52.5

638

3393

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

52.2

382

1662

Z01.2

ICD-10 Finland

Dental examination

1.5

52.0

2522

19438

R01AD58

ATC

fluticasone, combinations; nasal

1.6

51.8

1387

9319

E61.1

ICD-10 Finland

Iron deficiency

3.6

51.6

172

486

R03DC03

ATC

montelukast; oral

1.8

51.5

996

6132

J01DB01

ATC

cefalexin; oral

1.7

51.2

4653

41190

F32.1

ICD-10 Finland

Moderate depressive episode

2.4

51.1

370

1601

J02AC01

ATC

fluconazole; systemic

1.5

50.8

2305

17484

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

10.5

50.8

R00.2

ICD-10 Finland

Palpitations

2.1

50.6

498

2448

R01AD12

ATC

fluticasone furoate; nasal

1.6

50.6

1763

12606

R06AE07

ATC

cetirizine; oral

1.5

50.3

2499

19314

A01

ICPC

Pain general/multiple sites

2.0

50.0

583

3053

F90.0

ICD-10 Finland

Disturbance of activity and attention

3.1

49.7

211

694

M54

ICD-10 Finland

Dorsalgia

1.9

49.6

743

4232

R02

ICPC

Shortness of breath/dyspnoea

1.8

49.5

773

4461

L08

ICPC

Shoulder symptom/complaint

1.7

49.3

1260

8353

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.8

49.0

261

973

F34.1

ICD-10 Finland

Dysthymia

2.8

49.0

253

928

A02BC03

ATC

lansoprazole; oral

1.6

48.8

1620

11436

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.8

48.7

151

406

R52.2

ICD-10 Finland

Other chronic pain

2.7

48.5

264

996

N87

ICPC

Parkinsonism

4.2

48.3

131

320

N06BA04

ATC

methylphenidate; oral

3.2

48.1

194

619

WX780

NOMESCO Finland

Remote monitoring CPAP

2.7

47.8

274

1061

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

47.8

2040

15217

A98

ICPC

Health maint/preventive medicine

3.4

47.7

5571

52716

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

47.4

3650

30748

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.0

47.3

539

2797

M01AC06

ATC

meloxicam; systemic, rectal

1.5

47.2

2054

15373

L28

ICPC

Limited function/disability (L)

1.7

47.1

1021

6471

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

3.0

46.8

211

719

E0000UV, ,

ATC

1.5

46.3

2306

17736

K30

ICD-10 Finland

Functional dyspepsia

1.9

46.0

684

3882

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.0

45.8

582

3135

N06AB05

ATC

paroxetine; oral

2.3

45.4

382

1763

L15

ICPC

Knee symptom/complaint

1.6

45.1

1357

9331

SFA10

NOMESCO Finland

One-surface restoration

1.5

44.9

2991

24335

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

44.8

1059

6858

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

44.8

769

4557

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

44.8

777

4620

R05

ICPC

Cough

1.6

44.6

1347

9269

R01AD08

ATC

fluticasone; nasal

1.5

44.2

1601

11480

SFA20

NOMESCO Finland

Two-surface restoration

1.5

44.2

3184

26275

K02.1

ICD-10 Finland

Caries of dentine

1.5

44.1

3175

26192

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

43.9

684

3934

A02BC04

ATC

rabeprazole; oral

2.0

43.9

541

2883

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

43.5

593

3268

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

42.7

3913

33763

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

42.6

579

3187

R06AX27

ATC

desloratadine; oral

1.5

42.4

1577

11351

R25.1

ICD-10 Finland

Tremor, unspecified

2.8

42.4

213

770

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.2

42.1

168

533

R03BA08

ATC

ciclesonide; inhalant

2.0

41.9

529

2840

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

41.7

654

3767

L13

ICPC

Hip symptom/complaint

1.6

41.6

1064

7016

SPAT1301

SPAT

No procedures

1.5

41.6

1708

12549

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

41.2

2360

18532

R03BA02

ATC

budesonide; inhalant

1.6

41.1

1007

6569

H03AA01

ATC

levothyroxine sodium; systemic

1.6

40.9

1371

9633

AA40B, ,

NOMESCO Finland

8.1

40.5

UJF32

NOMESCO Finland

Coloscopy

1.5

40.5

1431

10169

G47.8

ICD-10 Finland

Other sleep disorders

4.0

40.3

115

292

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

40.2

3005

24775

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

40.1

977

6360

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

40.0

683

4033

J01CA04

ATC

amoxicillin; systemic

1.6

40.0

4514

40352

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

39.9

569

3179

N30.0

ICD-10 Finland

Acute cystitis

1.7

39.8

952

6166

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

39.8

777

4768

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

39.8

1333

9357

N06AA12

ATC

doxepin; systemic

2.3

39.7

319

1443

R60.0

ICD-10 Finland

Localized oedema

1.8

39.7

702

4189

SPAT1240

SPAT

Therapeutic discussion

1.9

39.4

585

3311

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.6

39.3

132

375

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

39.3

1070

7155

U02

ICPC

Urinary frequency/urgency

1.7

39.1

836

5258

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

38.9

2133

16554

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

38.7

1596

11703

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

38.6

1142

7782

N05AA02

ATC

levomepromazine; systemic

2.6

38.4

237

951

N05AX12

ATC

aripiprazole; systemic

2.6

38.3

228

899

XG466

NOMESCO Finland

Sleep oxymetry

2.8

38.2

196

717

N03AG01

ATC

valproic acid; systemic, rectal

2.2

38.2

351

1677

C07AB07

ATC

bisoprolol; oral

1.4

38.1

2565

20657

R51

ICD-10 Finland

Headache

2.2

38.1

336

1579

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

38.1

792

4941

XKD00

NOMESCO Finland

Uroflowmetry

1.7

38.0

719

4369

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.8

37.9

200

742

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.6

37.9

125

351

L02

ICPC

Back symptom/complaint

1.8

37.4

574

3279

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

37.1

491

2675

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

37.1

338

1609

R12

ICD-10 Finland

Heartburn

1.9

36.9

468

2513

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

36.8

2530

20410

N05AN01

ATC

lithium; oral

3.1

36.6

156

515

M01AH01

ATC

celecoxib; oral

1.6

36.5

997

6658

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

35.8

703

4313

R07.3

ICD-10 Finland

Other chest pain

1.8

35.7

577

3347

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

35.7

989

6626

N06BA07

ATC

modafinil; oral

8.2

35.4

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

35.4

529

2996

Z01.7

ICD-10 Finland

Laboratory examination

1.7

35.3

811

5186

N05AH03

ATC

olanzapine; systemic

2.1

35.3

344

1681

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

35.2

322

1535

P01AB01

ATC

metronidazole; oral, rectal

1.4

35.1

2177

17189

SPAT1263

SPAT

Sampling

1.4

35.1

2243

17807

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

34.8

2781

22955

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.7

34.8

633

3800

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.6

34.7

207

817

N03AX11

ATC

topiramate; oral

2.9

34.6

165

580

P20

ICPC

Memory disturbance

1.7

34.5

729

4558

TAB00

NOMESCO Finland

Lumbar puncture

2.3

34.5

264

1169

R21

ICPC

Throat symptom/complaint

1.6

34.5

1072

7369

F45.8

ICD-10 Finland

Other somatoform disorders

2.0

34.4

390

2014

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

34.3

377

1925

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

34.3

495

2771

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.4

34.3

125

375

A06AD11

ATC

lactulose; oral

1.7

34.2

759

4808

R74

ICPC

Upper respiratory infection acute

1.5

34.1

1640

12336

J20

ICD-10 Finland

Acute bronchitis

1.8

34.1

566

3308

C10AA07

ATC

rosuvastatin; oral

1.5

34.0

1678

12682

L12

ICPC

Hand/finger symptom/complaint

1.6

34.0

878

5776

L14

ICPC

Leg/thigh symptom/complaint

1.9

34.0

458

2508

D11

ICPC

Diarrhoea

1.7

34.0

638

3863

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.0

33.9

381

1962

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

33.8

1173

8255

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

8.8

33.6

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

33.5

327

1598

UKC02

NOMESCO Finland

Cystoscopy

1.6

33.5

789

5074

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

33.3

846

5540

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.9

33.2

468

2601

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.9

33.0

469

2612

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

33.0

888

5898

K59.0

ICD-10 Finland

Constipation

2.1

32.9

324

1588

IBA03

NOMESCO Finland

Psychotherapy evaluation

4.9

32.9

152

M02AA07

ATC

piroxicam; topical

1.4

32.6

1924

15007

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

3.2

32.4

132

424

A02BA02

ATC

ranitidine; systemic

1.5

32.2

1024

7061

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.7

32.1

618

3764

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.9

32.0

403

2158

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

31.9

1554

11688

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

31.9

1593

12038

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.7

31.9

180

692

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.8

31.8

159

574

N17

ICPC

Vertigo/dizziness

1.7

31.8

677

4238

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

31.7

1193

8527

R03BA05

ATC

fluticasone; inhalant

1.6

31.5

968

6622

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

31.4

496

2853

G04BD08

ATC

solifenacin; oral

2.0

31.4

382

2021

R4110, ,

SPAT

1.8

31.3

495

2850

U07

ICPC

Urine symptom/complaint other

1.9

31.2

423

2319

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.0

31.1

340

1733

ZY010

NOMESCO Finland

Hospital outpatient

2.2

30.8

281

1337

G04CA02

ATC

tamsulosin; oral

1.6

30.8

942

6433

G43.9

ICD-10 Finland

Migraine, unspecified

2.0

30.7

334

1698

D07AC01

ATC

betamethasone; topical

1.4

30.6

1903

14935

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

5.8

30.6

M01AX05

ATC

glucosamine; oral

1.5

30.6

1056

7406

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

8.5

30.5

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

30.3

1073

7564

R03BA01

ATC

beclometasone; inhalant

1.6

30.1

757

4938

G04CA01

ATC

alfuzosin; oral

1.8

30.0

523

3097

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

29.8

172

669

SFA30

NOMESCO Finland

Three-surface restoration

1.4

29.7

2201

17774

WX290

NOMESCO Finland

Other blockage of nerve

1.4

29.7

2378

19449

SPAT1216

SPAT

Assessment of functional ability

1.6

29.7

823

5494

G25.0

ICD-10 Finland

Essential tremor

2.7

29.6

161

607

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

29.6

701

4504

D01

ICPC

Abdominal pain/cramps general

1.7

29.6

630

3940

SPAT1260

SPAT

Consultation of another employee

1.5

29.6

928

6370

N06AX17

ATC

milnacipran; oral

3.9

29.4

227

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.2

29.2

240

1095

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.3

29.1

234

1058

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

29.1

448

2557

R11

ICD-10 Finland

Nausea and vomiting

1.8

29.0

474

2753

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

29.0

1215

8853

A11

ICPC

Chest pain NOS

1.8

29.0

452

2589

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

28.9

1074

7639

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

28.7

326

1683

P29

ICPC

Psychological sympt/compl other

1.9

28.7

359

1917

G43

ICD-10 Finland

Migraine

2.1

28.6

270

1302

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

28.6

316

1617

D82

ICPC

Teeth/gum disease

1.4

28.5

1891

14963

Z3231

NOMESCO Finland

Registered nurse

1.4

28.4

1402

10530

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.3

28.4

108

333

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.1

28.3

119

390

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

28.2

2023

16212

R03AK08

ATC

formoterol and beclometasone; inhalant

2.1

28.1

262

1257

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.7

28.1

147

544

R13

ICD-10 Finland

Dysphagia

1.9

28.0

390

2157

WX722

NOMESCO Finland

PEEP

2.2

27.8

244

1143

R03AC03

ATC

terbutaline; inhalant

1.6

27.7

751

4982

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

27.6

370

2021

A06AC51

ATC

ispaghula, combinations; oral

2.1

27.6

284

1416

F33

ICD-10 Finland

Recurrent depressive disorder

2.8

27.5

137

494

R03BB04

ATC

tiotropium bromide; inhalant

1.7

27.5

499

2987

M54.1

ICD-10 Finland

Radiculopathy

2.2

27.4

237

1105

S29

ICPC

Skin symptom/complaint other

1.5

27.2

1010

7170

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.7

27.1

150

571

H02AB07

ATC

prednisone; oral

1.6

27.1

722

4767

M03BX01

ATC

baclofen; systemic

2.9

27.1

124

427

J01FA10

ATC

azithromycin; systemic

1.4

27.1

3025

25929

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.9

27.0

126

438

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.6

26.9

160

631

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

26.9

1382

10440

J01MA02

ATC

ciprofloxacin; systemic

1.4

26.9

1980

15901

N30

ICD-10 Finland

Cystitis

1.8

26.9

456

2677

R06AX22

ATC

ebastine; oral

1.5

26.8

914

6373

A28

ICPC

Limited function/disability NOS

1.5

26.8

863

5948

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

26.6

368

2030

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

26.6

396

2236

OAA65, ,

SPAT

1.6

26.6

755

5059

SPAT1312

SPAT

General health counselling

1.4

26.4

1633

12733

P74

ICPC

Anxiety disorder/anxiety state

2.2

26.4

233

1095

SPAT1310

SPAT

Counselling related to known health issue

1.4

26.3

1642

12820

XA800

NOMESCO Finland

Neuropsychological investigation

2.2

26.3

228

1063

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.5

26.3

166

674

N39.3

ICD-10 Finland

Stress incontinence

1.8

26.3

436

2542

C10AA05

ATC

atorvastatin; oral

1.4

26.3

2092

16993

F61.0

ICD-10 Finland

Mixed personality disorders

3.2

26.3

104

329

IHZ05, ,

SPAT

2.5

26.2

173

718

M02AA10

ATC

ketoprofen; topical

1.5

26.2

845

5823

N06AG02

ATC

moclobemide; oral

2.1

26.1

247

1192

L86

ICPC

Back syndrome with radiating pain

1.9

26.1

342

1853

R5110, ,

SPAT

1.9

26.0

365

2022

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

25.9

804

5491

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.6

25.9

152

596

J01EA01

ATC

trimethoprim; systemic

1.4

25.8

1407

10729

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.7

25.7

144

552

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

25.7

210

957

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

25.5

4954

46285

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

25.4

1186

8790

L29

ICPC

Musculoskeletal sympt/complt other

1.7

25.4

466

2796

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

25.3

575

3649

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

25.3

2131

17433

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

25.1

197

883

Z2445

NOMESCO Finland

Psychologist

2.3

25.0

202

915

J01DA01

ATC

[U] cefalexin

1.3

25.0

3259

28430

Z3226

NOMESCO Finland

Physiotherapist

1.5

24.9

939

6678

SPAT1153

SPAT

Removal of sutures

1.4

24.8

1635

12858

SPAT1053

SPAT

Memory test

1.6

24.8

719

4836

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.1

24.7

229

1097

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.9

24.7

113

389

A97

ICPC

No disease

1.5

24.7

914

6474

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

24.7

456

2741

H81

ICPC

Excessive ear wax

1.5

24.6

859

6010

L16

ICPC

Ankle symptom/complaint

1.6

24.6

604

3906

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

24.6

1593

12488

N05BE01

ATC

buspirone; oral

2.4

24.6

165

690

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

24.5

750

5103

SDA03

NOMESCO Finland

Periodontal treatment

1.4

24.4

2053

16766

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

24.4

693

4638

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

24.3

163

681

R15

ICD-10 Finland

Faecal incontinence

2.3

24.3

177

768

G93.3

ICD-10 Finland

Postviral fatigue syndrome

6.0

24.2

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

8.9

24.2

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

24.0

1225

9217

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

24.0

2467

20741

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.0

23.9

275

1426

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

23.9

368

2098

N04BD01

ATC

selegiline; oral

3.2

23.8

292

A03CA02

ATC

clidinium and psycholeptics; oral

1.9

23.8

315

1713

N04AA02

ATC

biperiden; systemic

2.9

23.7

112

393

K07.60

ICD-10 Finland

Snapping jaw

2.0

23.6

282

1481

R96

ICPC

Asthma

1.7

23.6

517

3249

SPAT1307

SPAT

Psychosocial counselling and guidance

1.9

23.6

293

1560

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

23.6

1019

7433

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.3

23.6

173

753

J34.2

ICD-10 Finland

Deviated nasal septum

2.0

23.4

263

1353

M15

ICD-10 Finland

Polyarthrosis

1.9

23.4

295

1579

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

23.4

806

5622

A03FA02

ATC

cisapride; oral, rectal

1.8

23.3

397

2330

SPAT1254

SPAT

Administration of medicine

1.5

23.3

737

5049

H02

ICPC

Hearing complaint

1.5

23.2

696

4711

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

23.1

372

2149

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

23.0

707

4810

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.6

23.0

133

518

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.4

23.0

1377

10634

M01AH02

ATC

rofecoxib; oral

1.6

23.0

656

4392

D07AC13

ATC

mometasone; topical

1.4

22.9

1455

11345

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

22.8

419

2512

SPAT1058

SPAT

PEF monitoring instruction

1.7

22.8

434

2628

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

22.8

1417

11008

C05AA08

ATC

fluocortolone; rectal, topical

1.5

22.6

697

4746

S06.0

ICD-10 Finland

Concussion

1.6

22.4

532

3409

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

22.4

231

1152

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

22.3

1061

7871

KMAK, ,

NOMESCO Finland

1.3

22.2

2650

22659

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

22.2

3082

26911

M01AX17

ATC

nimesulide; oral

1.4

22.2

1221

9289

K08.80

ICD-10 Finland

Toothache NOS

1.7

22.2

448

2757

N02CC07

ATC

frovatriptan; oral

2.1

22.2

214

1042

R4110

NOMESCO Finland

Physiotherapy

1.4

22.1

1402

10920

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

22.1

1111

8322

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.8

21.9

370

2167

N04BC06

ATC

cabergoline; oral

5.1

21.9

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

21.8

1846

15021

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

21.7

2526

21501

Z00.0

ICD-10 Finland

General medical examination

1.4

21.6

961

7036

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

21.6

550

3584

M54.2

ICD-10 Finland

Cervicalgia

1.7

21.6

416

2527

D07AD01

ATC

clobetasol; topical

1.5

21.5

862

6187

R06AE09

ATC

levocetirizine; oral

1.5

21.5

732

5087

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

21.4

218

1082

N05AF03

ATC

chlorprothixene; systemic

2.5

21.4

139

573

G25.3

ICD-10 Finland

Myoclonus

8.3

21.4

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.3

21.4

156

678

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

21.3

1773

14379

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.5

21.3

137

562

SXC05

NOMESCO Finland

Other oral or dental procedure

1.8

21.3

322

1825

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

21.3

1825

14869

N76.0

ICD-10 Finland

Acute vaginitis

1.8

21.3

311

1745

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.5

21.2

134

545

H29

ICPC

Ear symptom/complaint other

1.6

21.2

585

3883

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.4

21.2

151

649

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.0

21.2

227

1149

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

21.1

647

4395

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

21.0

364

2147

N05AX08

ATC

risperidone; systemic

1.7

21.0

393

2368

N01

ICPC

Headache

1.6

20.9

529

3441

N02AJ13

ATC

tramadol and paracetamol; systemic

2.5

20.9

133

543

A99

ICPC

Disease/condition unspecnature/site

1.6

20.8

473

2997

K58

ICD-10 Finland

Irritable bowel syndrome

2.4

20.8

146

623

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

20.8

521

3380

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.7

20.8

110

410

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.2

20.8

175

808

Z2221

NOMESCO Finland

Medical doctor

1.4

20.7

1381

10823

C10AC01

ATC

colestyramine; oral

2.3

20.7

155

681

L60.0

ICD-10 Finland

Ingrowing nail

1.9

20.7

245

1284

H01

ICPC

Ear pain/earache

1.6

20.7

569

3775

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

20.7

396

2402

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

20.6

173

797

EB1MA

NOMESCO Finland

Cephalometry with X-ray

2.8

20.6

105

384

SBB10

NOMESCO Finland

Dental impressions

1.8

20.6

321

1836

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

20.6

1555

12422

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.1

20.5

277

E66.8

ICD-10 Finland

Other obesity

1.8

20.4

286

1584

U05

ICPC

Urination problems other

1.9

20.3

257

1378

N02CC05

ATC

almotriptan; oral

2.1

20.3

201

989

D12

ICPC

Constipation

2.1

20.2

192

929

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.2

20.2

254

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

20.2

522

3414

XA420

NOMESCO Finland

Extensive sleep examination

3.5

20.1

200

M03AX01

ATC

botulinum toxin; parenteral

3.1

20.1

260

ZXE00

NOMESCO Finland

One hour or less

1.3

20.0

1956

16199

J02AC02

ATC

itraconazole; systemic

1.4

20.0

904

6631

N06AA10

ATC

nortriptyline; systemic

2.5

19.9

127

519

S02

ICPC

Pruritus

2.1

19.9

188

908

XF402

NOMESCO Finland

ECG with work load test

1.6

19.9

526

3458

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

19.8

878

6415

E03

ICD-10 Finland

Other hypothyroidism

1.8

19.8

333

1947

XA421

NOMESCO Finland

Nocturnal polygraphy

5.2

19.8

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

19.8

224

1156

J05AB01

ATC

aciclovir; systemic

1.4

19.8

1117

8514

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

19.6

347

2058

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

19.6

228

1187

A01AB09

ATC

miconazole; local oral

1.6

19.6

434

2732

T83

ICPC

Overweight

2.5

19.6

118

470

C03CA01

ATC

furosemide; systemic

1.4

19.5

1390

10989

F48.0

ICD-10 Finland

Neurasthenia

6.8

19.5

SPAT1229

SPAT

Assessment of need for aid

1.7

19.5

392

2408

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

19.4

183

883

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

19.4

752

5355

AA400

NOMESCO Finland

Electroconvulsive therapy

3.9

19.4

144

M77.4

ICD-10 Finland

Metatarsalgia

1.8

19.3

318

1848

R83

ICPC

Respiratory infection other

1.4

19.3

1221

9477

OAB93, ,

SPAT

1.8

19.2

274

1525

SPAT1243

SPAT

Psychiatric/psychological examination

2.4

19.2

134

571

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

19.2

1025

7735

H93.1

ICD-10 Finland

Tinnitus

1.7

19.2

354

2125

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

19.2

921

6826

N06BA12

ATC

lisdexamfetamine; oral

3.8

19.1

150

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.8

19.1

150

C09CA06

ATC

candesartan; oral

1.4

19.1

1187

9180

G54.0

ICD-10 Finland

Brachial plexus disorders

2.3

19.1

142

622

D09

ICPC

Nausea

1.9

19.1

225

1177

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

19.0

3500

31415

EB1VA, ,

NOMESCO Finland

1.5

19.0

604

4132

D07AB08

ATC

desonide; topical

1.6

18.9

533

3553

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

18.9

1531

12327

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.9

18.9

307

SPAT1211

SPAT

Application of soft bandage

1.6

18.9

441

2814

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.2

18.8

151

684

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

18.7

225

1185

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

18.7

2017

16886

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

18.7

513

3398

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.0

18.7

266

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.8

18.7

331

J01FA06

ATC

roxithromycin; oral

1.3

18.6

2027

16995

H02AB04

ATC

methylprednisolone; systemic

1.5

18.5

727

5189

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

18.4

388

2412

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.5

18.3

113

455

D06

ICPC

Abdominal pain localized other

1.6

18.3

439

2817

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

18.3

908

6760

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

18.3

740

5309

DHB50

NOMESCO Finland

Turbinoplasty

2.3

18.3

138

609

D19

ICPC

Teeth/gum symptom/complaint

1.3

18.3

1372

10914

D50

ICD-10 Finland

Iron deficiency anaemia

2.4

18.3

122

510

G04BD09

ATC

trospium; oral

2.3

18.1

137

605

R01AD01

ATC

beclometasone; nasal

1.4

18.1

764

5526

R55

ICD-10 Finland

Syncope and collapse

1.5

18.1

523

3504

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.8

18.1

259

1444

R32

ICD-10 Finland

Unspecified urinary incontinence

2.2

18.0

156

729

E000001, ,

ATC

1.4

17.9

958

7225

J01FA09

ATC

clarithromycin; systemic

1.3

17.8

1556

12645

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

17.8

302

1772

J01CA08

ATC

pivmecillinam; oral

1.3

17.8

2186

18584

M43.1

ICD-10 Finland

Spondylolisthesis

1.9

17.7

211

1108

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

17.7

1274

10062

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

17.7

583

4015

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.0

17.7

269

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

17.7

897

6702

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.9

17.7

212

1117

ZYC01, ,

SPAT

1.6

17.6

429

2763

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.6

17.6

101

393

G62.8

ICD-10 Finland

Other specified polyneuropathies

3.6

17.6

164

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.6

17.6

164

SPAT1325

SPAT

Vaccination

1.3

17.6

1656

13591

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.6

17.6

382

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

17.5

650

4585

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

4.3

17.5

102

R50.9

ICD-10 Finland

Fever, unspecified

1.5

17.5

702

5027

P25

ICPC

Phase of life problem adult

1.9

17.5

208

1092

M70.7

ICD-10 Finland

Other bursitis of hip

2.2

17.4

148

686

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.0

17.3

251

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

4.0

17.3

120

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

6.0

17.3

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

4.4

17.3

R33

ICD-10 Finland

Retention of urine

1.7

17.3

330

2000

A08

ICPC

Swelling

1.8

17.2

262

1488

R39.1

ICD-10 Finland

Other difficulties with micturition

2.2

17.2

145

670

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

17.2

509

3429

N07BB01

ATC

disulfiram; oral

2.0

17.1

189

967

A05

ICPC

Feeling ill

1.8

17.1

273

1572

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

17.1

351

2166

A03

ICPC

Fever

1.4

17.1

781

5725

ZXA10

NOMESCO Finland

Bilateral

1.4

17.1

908

6834

G24.8

ICD-10 Finland

Other dystonia

5.8

17.1

F41.00

ICD-10 Finland

Moderate panic disorder

2.7

17.1

330

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

17.1

1176

9224

M75

ICD-10 Finland

Shoulder lesions

1.9

17.1

230

1259

G04CB01

ATC

finasteride; oral

1.6

17.0

391

2483

EBA00

NOMESCO Finland

Extraction of tooth

1.3

17.0

1704

14087

X58

ICD-10 Finland

Exposure to other specified factors

1.5

17.0

659

4690

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

16.8

394

2514

XKC03

NOMESCO Finland

Water cystometry

2.1

16.8

163

796

N02CC04

ATC

rizatriptan; oral

1.7

16.8

281

1641

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

16.8

611

4293

SPAT1283

SPAT

Restricted health certificate

1.4

16.8

753

5504

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

16.7

284

1667

XQ800

NOMESCO Finland

Prick test

1.6

16.7

364

2283

N06AB08

ATC

fluvoxamine; oral

2.2

16.7

146

686

ACC51

NOMESCO Finland

Release of median nerve

1.6

16.6

383

2434

P99

ICPC

Psychological disorders other

2.2

16.6

146

687

WX002

NOMESCO Finland

Sedation and analgesia

1.4

16.6

954

7272

R06AX13

ATC

loratadine; oral

1.4

16.6

737

5378

M76.0

ICD-10 Finland

Gluteal tendinitis

2.3

16.5

126

559

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

16.5

1752

14580

M54.3

ICD-10 Finland

Sciatica

1.7

16.5

311

1879

SPAT1234

SPAT

Support of social functional capacity

1.8

16.4

254

1451

S22

ICPC

Nail symptom/complaint

1.7

16.4

311

1882

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

16.3

1280

10220

WZC00, ,

SPAT

1.5

16.3

484

3260

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.8

16.3

226

1248

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

16.3

1096

8561

R01AD05

ATC

budesonide; nasal

1.6

16.2

377

2401

R30.0

ICD-10 Finland

Dysuria

1.9

16.2

212

1149

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

16.2

247

1404

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

16.2

311

1887

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

16.2

380

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.8

16.2

255

1464

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

16.1

431

2836

C10AX09

ATC

ezetimibe; oral

1.4

16.1

726

5309

J01MA06

ATC

norfloxacin; oral

1.4

16.1

649

4650

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.2

16.0

128

580

N89

ICPC

Migraine

2.1

16.0

157

771

N03AF01

ATC

carbamazepine; oral, rectal

1.8

16.0

239

1352

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

15.9

378

2421

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.7

15.9

292

1751

R03BC03

ATC

nedocromil; inhalant

1.6

15.9

339

2114

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

15.9

1895

15988

K07

ICPC

Swollen ankles/oedema

1.8

15.8

231

1296

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

15.8

234

1319

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.1

15.7

212

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

15.7

1115

8768

T82

ICPC

Obesity

1.9

15.7

196

1046

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

15.7

175

899

F29

ICPC

Eye symptom/complaint other

1.5

15.6

457

3069

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

15.6

619

4420

S21

ICPC

Skin texture symptom/complaint

1.4

15.6

685

4984

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

15.6

454

3046

S04

ICPC

Lump/swelling localized

1.5

15.6

497

3400

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.0

15.5

165

834

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

15.5

799

5979

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

15.4

482

3282

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

4.6

15.4

SPAT1051

SPAT

Guidance regarding sleep disorders

2.6

15.3

332

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

15.3

561

3947

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

15.3

1840

15523

N29

ICPC

Neurological sympt/complt other

2.4

15.3

105

446

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

15.2

849

6433

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

15.2

335

2107

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.1

15.2

134

632

UJD02

NOMESCO Finland

Gastroscopy

1.8

15.2

230

1306

ZA1.0

ICD-10 Finland

Shoulder region

2.2

15.1

123

561

L19

ICPC

Muscle symptom/complaint NOS

2.1

15.1

148

726

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

15.1

877

6689

D03

ICPC

Heartburn

1.9

15.1

180

948

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.0

15.1

172

892

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

15.0

516

3581

M19.8

ICD-10 Finland

Other specified arthrosis

1.9

15.0

197

1070

H57.1

ICD-10 Finland

Ocular pain

1.9

15.0

189

1013

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.3

15.0

167

M01AX01

ATC

nabumetone; oral

1.8

15.0

209

1157

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

14.8

1166

9299

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.2

14.8

122

560

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.8

14.8

258

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

14.8

307

1902

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.0

14.7

205

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

14.7

315

1968

G04BD07

ATC

tolterodine; oral

1.8

14.6

241

1402

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

14.6

254

1500

H92.0

ICD-10 Finland

Otalgia

1.7

14.6

291

1784

N02AA05

ATC

oxycodone; systemic

1.4

14.6

811

6139

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

14.6

254

1502

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

2.1

14.5

140

684

ZXA00

NOMESCO Finland

Right side

1.3

14.5

1277

10341

J01FF01

ATC

clindamycin; systemic

1.3

14.5

1305

10600

S22.3

ICD-10 Finland

Fracture of rib

1.6

14.4

324

2048

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

14.4

537

3789

C08CA05

ATC

nifedipine; systemic

1.7

14.4

275

1668

R4120

NOMESCO Finland

Occupational therapy

1.6

14.3

315

1980

A07EA06

ATC

budesonide; oral, local oral

1.9

14.3

175

929

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

14.3

375

2458

IAB01, ,

SPAT

5.5

14.3

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

14.3

436

2954

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

14.3

190

1037

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

14.3

344

2211

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.4

14.2

576

4126

SPAT1043

SPAT

Audiometry

1.5

14.2

491

3412

K02

ICD-10 Finland

Dental caries

1.6

14.2

331

2111

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

14.2

226

1303

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

14.2

415

2787

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

14.1

236

1380

SPAT1360

SPAT

Extensive global examination

1.6

14.1

333

2130

N05AE05

ATC

lurasidone; oral

5.1

14.1

F32.0

ICD-10 Finland

Mild depressive episode

2.1

14.1

132

638

R06.2

ICD-10 Finland

Wheezing

1.8

14.1

208

1173

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

14.0

1232

9963

G04BD11

ATC

fesoterodine; oral

2.0

14.0

146

733

U01

ICPC

Dysuria/painful urination

1.5

14.0

389

2581

E66

ICD-10 Finland

Obesity

1.7

14.0

242

1427

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

14.0

427

2892

D07AA02

ATC

hydrocortisone; topical

1.4

14.0

636

4652

N07CA01

ATC

betahistine; oral

1.6

14.0

352

2285

SFA00

NOMESCO Finland

Small restoration

1.4

14.0

664

4895

A01AB04

ATC

amphotericin B; local oral

1.8

13.9

227

1318

G44.0

ICD-10 Finland

Cluster headache syndrome

2.9

13.9

223

C09CA01

ATC

losartan; oral

1.3

13.8

1222

9888

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

13.8

913

7092

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.4

13.8

410

K80

ICPC

Cardiac arrhythmia NOS

1.5

13.8

394

2631

Z00.8

ICD-10 Finland

Other general examinations

1.6

13.8

360

2357

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

13.8

566

4065

-1, ,

NOMESCO Finland

1.3

13.8

1571

13130

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.1

13.8

124

590

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

2.3

13.8

105

467

R49.08

ICD-10 Finland

Other specified dysphonia

2.2

13.7

118

551

L11

ICPC

Wrist symptom/complaint

1.5

13.7

424

2879

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

13.7

298

1867

IGY02, ,

SPAT

3.1

13.7

187

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

13.7

1114

8914

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

13.7

200

1124

G50.1

ICD-10 Finland

Atypical facial pain

2.3

13.7

100

437

C08CA13

ATC

lercanidipine; oral

1.4

13.7

677

5025

I50

ICD-10 Finland

Heart failure

2.1

13.6

134

659

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

3.0

13.6

193

N02CC06

ATC

eletriptan; oral

1.9

13.6

169

902

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

13.6

239

1417

C01CA24

ATC

epinephrine; parenteral

1.6

13.6

293

1833

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

13.6

226

1320

G43.3

ICD-10 Finland

Complicated migraine

2.4

13.5

371

R4120, ,

SPAT

3.2

13.5

168

SXC06

NOMESCO Finland

Clinical work to produce sleep apnoea splint

4.5

13.5

IGY99, ,

SPAT

2.9

13.4

216

F51.5

ICD-10 Finland

Nightmares

16.2

13.4

SGA01

NOMESCO Finland

Emergency treatment

1.4

13.4

743

5619

B37.0

ICD-10 Finland

Candidal stomatitis

2.8

13.3

228

R30.1

ICD-10 Finland

Vesical tenesmus

2.2

13.3

107

487

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

13.2

509

3610

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.6

13.2

353

2322

ZXA05

NOMESCO Finland

Left side

1.3

13.2

1176

9518

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

13.2

254

1543

M54.8

ICD-10 Finland

Other dorsalgia

1.7

13.2

220

1285

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.1

13.2

121

580

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

3.1

13.2

181

AA1BG, ,

SPAT

2.4

13.2

394

G03FA01

ATC

norethisterone and estrogen; systemic

1.4

13.2

691

5176

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

13.1

519

3702

Z2446

NOMESCO Finland

Social worker

1.6

13.1

291

1834

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.7

13.0

242

K29

ICPC

Cardiovascular sympt/complt other

1.8

13.0

202

1156

K04.08

ICD-10 Finland

Other specified pulpit

1.6

13.0

330

2146

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.9

13.0

174

952

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

13.0

209

1209

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.2

13.0

113

531

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

13.0

385

2593

OAB42, ,

SPAT

1.5

13.0

460

3213

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.3

13.0

441

SPAT1377

SPAT

Polysomnography

1.9

13.0

159

846

R29

ICPC

Respiratory symptom/complaint other

1.6

12.9

318

2053

N05

ICPC

Tingling fingers/feet/toes

2.7

12.9

243

U13

ICPC

Bladder symptom/complaint other

1.9

12.8

149

778

J01AA04

ATC

lymecycline; systemic

1.4

12.8

589

4313

J46

ICD-10 Finland

Status asthmaticus

2.0

12.8

143

737

N81.6

ICD-10 Finland

Rectocele

1.6

12.8

341

2243

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

12.8

339

2227

M35.7

ICD-10 Finland

Hypermobility syndrome

2.5

12.8

320

R07.0

ICD-10 Finland

Pain in throat

1.6

12.8

317

2051

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.2

12.8

107

495

R03AC13

ATC

formoterol; inhalant

1.7

12.8

241

1457

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

12.8

973

7709

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

12.8

497

3534

R03AK11

ATC

formoterol and fluticasone; inhalant

2.0

12.7

127

629

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.5

12.7

333

F31

ICD-10 Finland

Bipolar affective disorder

2.8

12.7

223

A29

ICPC

General symptom/complaint other

1.4

12.7

582

4262

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

12.7

390

2647

H13

ICPC

Plugged feeling ear

1.3

12.7

887

6944

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

12.7

771

5912

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.1

12.6

118

570

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

12.6

228

1363

K07.4

ICD-10 Finland

Malocclusion, unspecified

2.4

12.6

371

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

12.6

381

2576

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

12.6

348

2308

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

12.5

1296

10681

K04.0

ICD-10 Finland

Pulpitis

1.5

12.5

414

2850

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.6

12.5

270

H02.3

ICD-10 Finland

Blepharochalasis

1.6

12.5

315

2045

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

12.5

562

4100

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.4

12.5

360

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.1

12.5

171

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

12.5

461

3244

M01AB55

ATC

diclofenac, combinations; oral

1.6

12.4

315

2048

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

12.4

805

6228

P02

ICPC

Acute stress reaction

1.7

12.4

229

1376

SPAT1281

SPAT

Other administrative function

1.5

12.4

361

2423

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

12.3

216

1280

SPAT1252

SPAT

Overall medication plan or its review

1.6

12.3

306

1982

ZXD20

NOMESCO Finland

Day surgery

1.4

12.3

606

4493

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.2

12.3

104

484

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

12.3

671

5059

GD1AA, ,

SPAT

1.4

12.2

524

3790

C08CA01

ATC

amlodipine; oral

1.2

12.2

1807

15519

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.2

12.2

101

466

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

12.2

1000

8000

C01DA14

ATC

isosorbide mononitrate; oral

1.4

12.2

631

4716

S09

ICPC

Infected finger/toe

1.9

12.1

153

822

N02CC03

ATC

zolmitriptan; nasal, oral

1.6

12.1

256

1594

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.1

12.1

113

546

M15.8

ICD-10 Finland

Other polyarthrosis

2.1

12.1

106

500

L09

ICPC

Arm symptom/complaint

1.7

12.1

228

1379

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

12.1

598

4435

C03DA01

ATC

spironolactone; oral

1.4

12.1

530

3851

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

12.1

214

1273

J30.3

ICD-10 Finland

Other allergic rhinitis

1.8

12.1

162

888

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.6

12.0

264

A07AA02

ATC

nystatin; oral

1.6

12.0

284

1817

TQW40, ,

SPAT

1.5

12.0

341

2275

A02BA04

ATC

nizatidine; systemic

1.5

12.0

342

2284

F40.1

ICD-10 Finland

Social phobias

2.1

11.9

105

496

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.3

11.9

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.1

11.9

104

490

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

11.9

575

4247

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

11.9

348

2337

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.7

11.9

202

1188

J01MA12

ATC

levofloxacin; systemic

1.3

11.9

829

6483

R1250

NOMESCO Finland

Evaluation of functional capability

2.1

11.9

111

537

K04

ICPC

Palpitations/awareness of heart

1.6

11.8

250

1557

KCV04

NOMESCO Finland

Distension of bladder with fluid

2.9

11.8

193

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.6

11.8

255

L04

ICPC

Chest symptom/complaint

1.6

11.8

295

1913

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.7

11.8

196

1145

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

11.8

435

3061

J05AB11

ATC

valaciclovir; oral

1.4

11.7

681

5180

U71

ICPC

Cystitis/urinary infection other

1.5

11.7

327

2173

C10AA01

ATC

simvastatin; oral

1.2

11.7

1938

16821

SPAT1104

SPAT

Monitoring of emergency patient

1.6

11.7

304

1989

D10

ICPC

Vomiting

1.6

11.7

245

1523

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

11.7

729

5609

R07

ICPC

Sneezing/nasal congestion

1.6

11.6

289

1872

WX320

NOMESCO Finland

Spinalanesthesy

1.3

11.6

1160

9509

WZC30

NOMESCO Finland

Teaching

1.3

11.6

733

5647

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

11.6

257

1620

F01

ICPC

Eye pain

1.9

11.6

133

693

EB1AA, ,

SPAT

1.5

11.6

311

2051

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.8

11.5

155

850

D02

ICPC

Abdominal pain epigastric

1.6

11.5

286

1852

T07

ICPC

Weight gain

2.5

11.5

282

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

3.4

11.5

118

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

11.4

199

1178

SPAT1097

SPAT

Recording of ECG

1.4

11.4

675

5148

IHZ04, ,

SPAT

2.8

11.4

197

N07BA03

ATC

varenicline; oral

1.7

11.4

206

1233

SPAT1284

SPAT

Extensive health certificate

2.0

11.3

124

636

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.6

11.3

267

1710

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.9

11.3

139

742

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

11.2

505

3683

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.6

11.2

284

1847

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

9.6

11.2

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.8

11.2

188

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

11.2

155

859

N41.1

ICD-10 Finland

Chronic prostatitis

2.2

11.2

424

S14

ICPC

Burn/scald

1.8

11.1

155

860

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.0

11.1

113

564

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

11.1

1300

10851

M77.1

ICD-10 Finland

Lateral epicondylitis

1.5

11.1

351

2396

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

11.1

1201

9937

A10BJ02

ATC

liraglutide; parenteral

1.9

11.1

131

690

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

11.0

281

1830

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

11.0

315

2105

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

3.9

11.0

C10AA04

ATC

fluvastatin; oral

1.5

11.0

379

2633

X14

ICPC

Vaginal discharge

2.2

11.0

440

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.6

10.9

273

1773

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

10.9

579

4344

X15

ICPC

Vaginal symptom/complaint other

1.8

10.8

166

948

S80.0

ICD-10 Finland

Contusion of knee

1.5

10.8

336

2285

R31

ICD-10 Finland

Unspecified haematuria

1.5

10.8

402

2833

M01AH03

ATC

valdecoxib; oral

1.6

10.8

278

1816

J01AA07

ATC

tetracycline; systemic

1.3

10.8

677

5209

OAB44, ,

SPAT

1.5

10.8

338

2304

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

2.8

10.8

181

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.9

10.7

140

761

UJH02

NOMESCO Finland

Anoscopy

1.7

10.7

191

1138

NA3BG, ,

SPAT

1.7

10.7

173

1003

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

10.7

1627

13966

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.7

10.7

172

996

N06AX18

ATC

reboxetine; oral

2.5

10.7

250

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

10.7

332

2259

NA1BG, ,

SPAT

2.3

10.7

361

R61

ICD-10 Finland

Hyperhidrosis

2.8

10.7

182

J45.8

ICD-10 Finland

Mixed asthma

1.8

10.6

145

800

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.9

10.6

133

714

B35.1

ICD-10 Finland

Tinea unguium

1.5

10.6

281

1847

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

10.6

1442

12231

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

10.6

337

2304

AA1CG, ,

SPAT

2.6

10.5

217

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.6

10.5

228

1431

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.8

10.5

155

877

H01.0

ICD-10 Finland

Blepharitis

1.5

10.4

290

1927

L84

ICPC

Back syndrome without radiat pain

1.6

10.4

226

1418

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

10.4

582

4400

IAA01, ,

SPAT

3.7

10.4

G47

ICD-10 Finland

Sleep disorders

5.4

10.4

L05

ICPC

Flank/axilla symptom/complaint

1.5

10.4

274

1801

G57.6

ICD-10 Finland

Lesion of plantar nerve

2.0

10.4

107

538

L29

ICD-10 Finland

Pruritus

2.3

10.4

309

SCA02

NOMESCO Finland

Preventive oral health care

1.4

10.3

427

3072

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

2.4

10.3

304

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

10.2

153

868

M19

ICD-10 Finland

Other arthrosis

2.0

10.2

114

589

H60.8

ICD-10 Finland

Other otitis externa

1.8

10.2

137

752

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

10.2

329

2255

WX402

NOMESCO Finland

General anaesthesia

1.3

10.2

966

7854

S93.2

ICD-10 Finland

Rupture of ligaments at ankle and foot level

2.3

10.2

305

L20

ICPC

Joint symptom/complaint NOS

1.7

10.2

169

989

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

10.2

616

4714

G24.3

ICD-10 Finland

Spasmodic torticollis

2.7

10.2

204

G03DB01

ATC

dydrogesterone; oral

1.4

10.2

579

4390

R07.2

ICD-10 Finland

Precordial pain

2.0

10.1

102

508

L30.4

ICD-10 Finland

Erythema intertrigo

2.4

10.1

275

S20.2

ICD-10 Finland

Contusion of thorax

1.6

10.1

224

1412

N94.1

ICD-10 Finland

Dyspareunia

2.5

10.1

245

WZC30, ,

SPAT

1.6

10.1

245

1578

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

2.2

10.1

350

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.9

10.1

118

619

B07.9

ICD-10 Finland

Verruca simplex

1.8

10.1

157

901

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

10.1

270

1779

H50.52

ICD-10 Finland

Exophoria

2.6

10.1

222

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

10.1

312

2121

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.2

10.0

377

TDA90, ,

SPAT

1.6

10.0

228

1447

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.9

10.0

115

600

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

10.0

972

7925

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

10.0

259

1695

R49.03

ICD-10 Finland

Atrophic dysphonia

2.5

10.0

229

SPAT1237

SPAT

Psychotherapy

3.3

10.0

109

X72

ICPC

Genital candidiasis female

2.6

9.9

212

L29.8

ICD-10 Finland

Other pruritus

2.4

9.9

290

B80

ICPC

Iron deficiency anaemia

1.9

9.9

114

595

S94

ICPC

Ingrowing nail

2.2

9.9

353

D06BB03

ATC

aciclovir; topical

1.6

9.9

216

1357

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

9.9

212

1326

L99

ICPC

Musculoskeletal disease other

2.0

9.9

104

527

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

2.6

9.9

213

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

3.1

9.9

125

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.8

9.8

148

842

SPAT1238

SPAT

Brief therapy

2.2

9.8

342

M77.9

ICD-10 Finland

Enthesopathy, unspecified

1.8

9.8

146

828

R75

ICPC

Sinusitis acute/chronic

1.6

9.8

219

1385

M65.3

ICD-10 Finland

Trigger finger

1.6

9.8

216

1363

G03FB05

ATC

norethisterone and estrogen; systemic

1.4

9.7

524

3941

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

9.7

427

3106

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

9.6

245

1597

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

9.6

500

3735

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

9.6

1048

8660

N03AF02

ATC

oxcarbazepine; oral

1.8

9.6

141

796

N05CD02

ATC

nitrazepam; oral

2.2

9.6

345

E000002, ,

ATC

1.4

9.6

475

3520

K27

ICPC

Fear cardiovascular disease other

2.6

9.6

216

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

2.2

9.6

339

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.8

9.6

137

768

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.3

9.5

848

6837

K03.00

ICD-10 Finland

Approximal wear

1.5

9.5

302

2064

Z08

ICPC

Social welfare problem

2.4

9.5

265

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

9.5

446

3278

XA402

NOMESCO Finland

ENMG

1.9

9.5

116

619

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

3.8

9.5

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

9.5

243

1588

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.8

9.5

140

793

L91

ICPC

Osteoarthrosis other

2.0

9.4

474

R40.0

ICD-10 Finland

Somnolence

4.1

9.4

R52.1

ICD-10 Finland

Chronic intractable pain

2.7

9.4

189

A02BX02

ATC

sucralfate; oral

1.7

9.4

174

1049

SFC92

NOMESCO Finland

Other complicated additional procedure necessary for restorative treatment

1.5

9.4

285

1930

D02AE01

ATC

carbamide; topical

1.5

9.4

280

1890

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.7

9.4

150

869

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.0

9.4

489

B35.3

ICD-10 Finland

Tinea pedis

1.6

9.3

189

1167

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

3.5

9.3

L84

ICD-10 Finland

Corns and callosities

1.7

9.3

155

908

R06.4

ICD-10 Finland

Hyperventilation

2.2

9.3

337

R01AD11

ATC

triamcinolone; nasal

1.4

9.3

389

2802

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

9.3

256

1699

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.6

9.3

207

1309

F51.1

ICD-10 Finland

Nonorganic hypersomnia

8.7

9.3

OAB91, ,

SPAT

1.5

9.2

245

1613

D10AX03

ATC

azelaic acid; topical

1.5

9.2

286

1946

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.4

9.2

269

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.3

9.2

294

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

9.2

260

1735

N02CD03

ATC

fremanezumab; systemic

2.8

9.2

163

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.9

9.2

118

640

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4112

20933

4.45

307.65

3.6

2.8

100.60

120.97

ug/l

9.54

3767

19389

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2257

12098

2.43

216.42

2.5

2.2

2.72

2.96

mg/l

6.41

1921

10334

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3150

19812

2.32

205.07

2.3

2.0

99.50

96.27

pmol/l

2.99

1619

10049

(3022948) Iron [Moles/volume] in Serum or Plasma

1518

7474

2.40

168.67

2.4

2.5

14.60

13.04

umol/l

11.65

1395

6975

(3021960) Folate [Moles/volume] in Serum or Plasma

1995

11051

2.24

167.72

1.6

1.5

20.81

20.70

nmol/l

0.09

1727

9438

(3013707) Erythrocyte sedimentation rate by Westergren method

4645

36002

2.56

166.74

4.7

4.1

11.07

12.37

mm/h

10.06

4321

33325

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1390

6876

2.35

150.54

2.4

2.5

2.43

2.34

g/l

7.52

1270

6368

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2366

14479

2.08

149.84

2.3

2.1

172.97

206.84

u/l

1.26

2210

13557

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4761

37951

2.53

149.69

5.2

4.1

14.76

14.77

pmol/l

0.12

4381

34557

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5298

44781

3.55

145.32

6.5

4.9

1.82

2.07

mu/l

3.02

4938

41105

(3015377) Calcium [Moles/volume] in Serum or Plasma

2542

16627

1.95

127.40

2.7

3.4

2.35

2.36

mmol/l

0.37

2206

14564

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4611

37156

2.25

125.83

7.3

7.5

75.44

77.93

u/l

4.49

4340

34995

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1265

6428

2.24

125.79

2.5

2.6

23.73

22.63

1.87

1084

5482

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3353

24165

1.94

124.53

6.0

6.6

1.22

mmol/l

0.28

2865

20500

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3107

21854

1.93

123.97

5.5

5.9

1.22

1.21

mmol/l

0.56

2827

19902

(3019309) Folate [Moles/volume] in Red Blood Cells

1573

8932

2.05

115.99

1.9

1.7

1185.24

1173.08

nmol/l

0.19

1191

6761

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2922

20467

1.88

114.67

2.4

2.3

78.82

77.96

nmol/l

0.91

2625

18395

(40760892) CBC W Ordered Manual Differential panel - Blood

3112

22591

1.83

105.36

6.2

6.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5423

48088

3.56

104.86

17.1

14.1

19.85

23.16

mg/l

12.96

4497

38173

(3031040) Bacteria [#/volume] in Urine by Automated count

4031

31996

1.88

99.05

5.7

4.5

657.62

1637.22

e6/l

1.60

407

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5087

43929

2.45

98.58

6.6

5.6

39.38

39.58

mmol/mol

0.91

4737

40626

(3019550) Sodium [Moles/volume] in Serum or Plasma

5487

49296

3.92

97.83

19.5

16.1

139.60

139.67

mmol/l

1.29

5395

48097

(3023103) Potassium [Moles/volume] in Serum or Plasma

5496

49439

4.01

97.56

19.7

16.2

3.97

3.96

mmol/l

0.79

5401

48143

(3037467) Urinalysis macro (dipstick) panel - Urine

4144

33328

1.89

95.87

5.1

4.4

—

(3006315) Basophils [#/volume] in Blood

3230

24103

1.78

95.82

6.0

5.8

0.04

e9/l

0.17

2818

20784

(3013115) Eosinophils [#/volume] in Blood

3314

24927

1.79

95.55

6.3

6.0

0.19

e9/l

0.48

2939

21855

(3001604) Monocytes [#/volume] in Blood

3215

24041

1.77

93.86

6.0

5.8

0.56

0.58

e9/l

5.46

2810

20755

(3019198) Lymphocytes [#/volume] in Blood

3283

24732

1.77

93.07

6.1

5.9

1.93

1.92

e9/l

0.10

2929

21866

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1342

7706

1.97

92.79

2.5

3.3

0.83

0.82

mmol/l

6.78

1216

7206

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1720

10877

1.83

87.46

1.4

1.3

1.59

1.67

u/ml

0.07

467

2911

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1435

8602

1.89

86.31

1.3

23.83

30.91

iu/ml

2.14

426

2755

(3024561) Albumin [Mass/volume] in Serum or Plasma

2838

20813

1.72

85.61

4.1

4.8

36.23

35.54

g/l

10.15

2619

19325

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5235

46520

2.51

82.39

5.5

4.5

5.89

5.90

mmol/l

0.33

4847

42439

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5134

45346

2.31

80.08

15.3

13.1

80.97

80.96

ml/min/173m2

0.01

4362

37520

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1614

10343

1.78

76.61

1.7

14147873.00

29554858.49

pmol/l

0.72

1343

8618

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3892

31655

1.72

75.57

3.6

3.1

43.31

46.87

u/l

1.68

3624

29422

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1448

9042

1.81

74.71

2.6

3.0

2.44

2.45

mmol/l

5.01

1264

7896

(3013650) Neutrophils [#/volume] in Blood by Automated count

3523

27978

1.68

74.01

8.2

9.1

4.06

4.07

e9/l

0.03

3117

24404

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1337

8213

1.82

72.52

1.3

10.62

11.68

u/ml

0.22

503

3196

(3015736) pH of Urine

2583

19051

1.65

71.61

3.8

3.5

5.94

5.87

0.47

187

1391

(3013826) Glucose [Moles/volume] in Serum or Plasma

3521

28081

1.66

71.56

4.8

4.6

6.47

6.67

mmol/l

8.34

3319

26216

(3019069) Monocytes/100 leukocytes in Blood

2966

22669

1.64

71.21

6.4

6.3

8.33

8.55

3.84

2767

21180

(3018010) Neutrophils/100 leukocytes in Blood

2996

22960

1.64

71.12

6.0

5.9

56.89

57.20

0.79

2790

21475

(3006504) Eosinophils/100 leukocytes in Blood

2951

22534

1.64

71.04

6.1

6.0

2.94

2.84

1.51

2743

21015

(3002030) Lymphocytes/100 leukocytes in Blood

3027

23266

1.64

70.95

6.2

6.1

28.47

27.97

1.80

2821

21787

(40768797) Stomach Pathology biopsy report

1148

6798

1.86

69.77

1.3

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2448

17899

1.64

69.61

4.2

3.6

245.20

48.55

ng/l

0.51

1639

12038

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5528

51126

3.58

68.87

12.2

10.4

25.44

25.68

u/l

0.51

5374

49290

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

960

5393

1.94

68.47

1.9

1.7

1.45

0.05

849

4774

(3021601) Nitrite [Presence] in Urine by Test strip

3056

23674

1.63

68.31

5.4

5.0

0.00

estimate

0.80

591

4412

(3018418) pH of Serum or Plasma

2056

14441

1.66

68.07

3.6

4.0

7.40

0.77

373

2735

(1002224) Polysomnography panel

452

1892

2.51

67.53

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

3050

23680

1.62

67.03

4.1

3.8

0.00

estimate

2.18

602

4688

(3009261) Glucose [Presence] in Urine by Test strip

3074

23913

1.62

67.01

4.2

3.8

0.01

0.00

estimate

0.36

571

4329

(3022096) Basophils/100 leukocytes in Blood

2855

21834

1.62

66.61

6.1

0.70

0.68

1.22

2648

20310

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3181

25025

1.61

65.58

5.0

6.1

10.44

11.16

umol/l

3.08

2988

23733

(40761511) CBC panel - Blood by Automated count

5436

50027

2.82

64.18

16.0

13.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1460

9483

1.73

64.12

1.5

2.20

2.41

g/l

4.45

844

5749

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5299

48275

2.36

62.58

5.6

4.8

2.74

2.78

mmol/l

2.55

4930

44520

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1614

10833

1.68

62.48

1.7

1.12

1.17

mg/l

0.16

1195

8259

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2106

15128

1.62

62.32

2.6

2.5

55.78

64.76

u/l

0.99

1921

13930

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1899

13369

1.63

60.58

3.1

3.0

1197.54

1362.31

ng/l

0.59

1597

11454

(3026493) Urate [Moles/volume] in Serum or Plasma

1781

12426

1.63

58.46

2.5

2.6

1839.61

4608.56

umol/l

4.51

1530

10864

(3036481) Cortisol [Moles/volume] in Serum or Plasma

812

4530

1.92

58.39

2.2

361.90

373.72

nmol/l

0.91

756

4153

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

607

3061

2.10

58.03

1.3

50.68

52.88

au/ml

0.08

170

(3009542) Hematocrit [Volume Fraction] of Blood

5632

53252

5.33

56.93

26.5

20.9

40.22

40.07

0.68

5402

49873

(3048689) Calprotectin [Mass/mass] in Stool

991

5936

1.81

56.80

2.0

2.2

119.09

135.08

ug/g

0.73

762

4662

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

646

3360

2.04

56.75

2.5

2.4

29.99

23.51

au/ml

0.50

253

(3007461) Platelets [#/volume] in Blood

5632

53303

5.25

55.75

26.5

20.8

253.49

253.77

e9/l

0.12

5556

51992

(3024731) MCV [Entitic volume]

5632

53323

5.22

55.29

26.4

20.7

91.16

91.02

1.80

5587

52579

(3035941) MCH [Entitic mass]

5632

53324

5.22

55.27

26.4

20.7

30.30

30.27

0.68

5587

52578

(3018095) Leukocytes [#/volume] in Urine

2260

16854

1.56

55.12

4.0

3.7

75.09

102.83

e6/l

0.49

1609

11797

(3026361) Erythrocytes [#/volume] in Blood

5632

53331

5.21

55.11

26.5

20.8

4.46

4.47

e12/l

0.63

5536

51871

(3000963) Hemoglobin [Mass/volume] in Blood

5632

53343

5.19

54.83

26.7

20.9

134.35

134.53

g/l

0.45

5587

52604

(3010813) Leukocytes [#/volume] in Blood

5631

53327

5.15

54.83

26.5

20.8

6.72

6.69

e9/l

0.30

5538

51857

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5195

47388

2.07

54.04

5.0

4.4

4.64

4.71

mmol/l

5.35

4846

43926

(3037522) Nuclear Ab [Titer] in Serum

1073

6670

1.75

53.88

1.4

644.42

557.64

titre

0.49

208

1441

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5163

47064

2.02

52.70

4.9

4.3

1.47

1.49

mmol/l

5.44

4787

43382

(4200892) Spirometry reversibility

632

3411

1.96

49.67

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3625

30350

1.53

49.67

3.2

3.0

—

(36304419) Bacteria [Presence] in Urine

1784

12891

1.56

48.46

3.2

3.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5009

45448

1.83

48.38

4.4

3.9

1.31

1.29

mmol/l

1.99

4595

41535

(3011397) Hemoglobin [Presence] in Urine by Test strip

1576

11277

1.55

43.84

4.2

3.7

—

(3030467) Casts [#/volume] in Urine by Automated count

1794

13239

1.52

43.12

3.3

3.1

0.26

0.42

e6/l

4.48

1370

10018

(3002582) Erythrocytes [#/volume] in Urine

1906

14338

1.49

41.35

3.4

3.2

51.39

81.35

e6/l

1.06

1472

10915

(3028707) Methadone [Presence] in Urine by Screen method

194

688

2.88

40.02

2.5

2.9

—

(3044889) 12 lead EKG panel

3872

33553

1.48

39.49

4.3

3.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2703

21914

1.44

39.12

15.6

14.8

1.19

1.25

inr

2.87

800

6395

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2030

15652

1.46

38.06

3.0

3.2

29.74

35.31

u/l

3.58

1914

14838

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

356

1722

2.14

37.50

1.7

3.23

4.02

mg/l

0.86

311

1278

(3000850) Epithelial cells [#/volume] in Urine

1387

10037

1.50

35.24

2.5

2.6

5.83

6.03

e6/l

0.10

1243

8967

(3017446) Testosterone [Moles/volume] in Serum or Plasma

493

2734

1.88

35.24

2.7

2.2

12.73

12.45

nmol/l

0.30

452

2438

(3019225) pH of Specimen

766

4860

1.67

34.30

4.4

4.3

—

(3026008) Bacteria identified in Urine by Culture

1969

15348

1.43

33.75

3.3

3.1

—

(3011288) Drugs identified in Urine by Screen method

244

1068

2.34

32.75

3.0

—

(3000492) Spirometry study

727

4613

1.66

32.43

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

238

1047

2.33

31.58

2.0

1.7

39.70

41.82

nmol/l

0.68

233

1011

(3027945) Reticulocytes/100 erythrocytes in Blood

792

5179

1.61

31.25

2.3

2.5

1.71

1.79

1.49

675

4588

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2256

18197

1.40

31.07

4.4

4.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

417

2280

1.89

31.05

1.2

1.1

341.54

160.88

titre

0.42

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1145

8146

1.51

31.02

2.9

2.7

1.10

1.24

e6/l

0.38

672

4584

(1001926) Buprenorphine [Presence] in Urine by Screen method

262

1210

2.22

30.97

2.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

562

3370

1.74

30.85

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

311

1541

2.08

30.70

2.2

—

(3016879) Cocaine [Presence] in Urine

295

1434

2.11

30.63

2.2

2.3

—

(3029937) Albumin [Presence] in Urine by Test strip

1654

12685

1.43

30.25

4.8

4.2

0.01

0.00

estimate

0.25

580

4280

(3002385) Erythrocyte distribution width [Ratio]

4549

41431

1.48

30.15

19.5

16.8

15.49

14.93

6.47

4499

40687

(36660697) Celiac disease serology panel - Serum

631

3929

1.68

30.14

1.2

—

(40758558) Short blood count panel - Blood

1613

12327

1.43

30.04

6.2

6.8

—

(3028300) Cannabinoids [Presence] in Urine

311

1556

2.06

29.91

2.2

—

(3009508) Creatinine [Moles/volume] in Urine

1867

14655

1.41

29.84

3.2

7.46

7.30

mmol/l

0.80

1559

12377

(3027008) Opiates [Presence] in Urine

310

1551

2.06

29.81

2.2

2.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

346

1811

1.97

29.32

1.6

—

(40768804) Tissue Pathology biopsy report

2450

20169

1.38

29.23

2.2

2.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

368

1975

1.92

28.96

1.3

0.74

1.29

u/ml

0.42

187

(3019150) Specific gravity of Urine by Refractometry

1382

10338

1.44

28.69

4.8

4.2

1.02

kg/l

0.75

181

1564

(3013512) EKG study

1770

13844

1.40

28.60

4.2

3.9

—

(3027944) Amphetamines [Presence] in Urine

302

1520

2.04

28.57

2.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

183

749

2.49

28.51

2.1

1.9

197.82

201.17

pmol/l

0.13

174

703

(3021589) Normoblasts [#/volume] in Blood

2556

21275

1.36

28.04

10.1

9.5

0.00

e9/l

1.09

2108

17313

(3003327) Ova and parasites identified in Stool by Light microscopy

307

1588

1.99

26.90

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1059

7617

1.48

26.71

1.9

1.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

479

2863

1.73

26.47

3.3

3.6

5.17

5.16

kpa

0.10

454

2722

(3005322) IgE [Units/volume] in Serum or Plasma

495

2995

1.71

26.17

1.3

156.77

203.08

u/ml

1.16

460

2768

(3044640) Blood type and Crossmatch panel - Blood

1923

15438

1.37

25.92

2.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

243

1170

2.12

25.87

1.2

1.3

546.55

522.58

mg/l

0.11

228

1108

(3004588) Protein electrophoresis panel - Serum or Plasma

526

3249

1.68

25.74

1.8

2.3

—

(3009343) pH of Capillary blood

471

2826

1.73

25.66

3.3

3.6

7.43

7.42

1.20

358

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

512

3160

1.68

25.12

3.4

3.3

4.45

4.46

pmol/l

0.17

440

2805

(3022145) Colonoscopy Study observation

786

5398

1.53

24.62

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

606

3927

1.61

24.49

1.9

2.6

67.17

66.45

g/l

1.72

552

3587

(3003458) Phosphate [Moles/volume] in Serum or Plasma

866

6090

1.50

24.20

4.7

5.8

1.03

1.04

mmol/l

0.26

801

5654

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

217

1031

2.15

23.92

1.2

1.3

3.76

3.78

mmol/l

0.12

204

970

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

452

2735

1.71

23.84

3.3

3.6

1.51

1.89

mmol/l

1.50

348

2035

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

324

1778

1.87

23.79

3.5

3.8

24.78

24.91

mmol/l

0.41

304

1636

(3033658) Prothrombin time (PT) actual/Normal

1556

12208

1.38

23.74

3.9

3.8

91.82

91.08

0.52

1499

11893

(3000570) Elastase.pancreatic [Mass/mass] in Stool

278

1452

1.96

23.69

1.4

292.33

282.80

ug/g

0.34

173

832

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

424

2530

1.73

23.52

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

202

943

2.18

23.28

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2662

22688

1.32

23.26

2.5

2.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1132

8457

1.42

22.93

1.6

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

530

3389

1.62

22.56

1.3

1.2

109.62

144.84

iu/ml

1.20

202

1259

(3022313) Gas panel - Capillary blood

356

2051

1.78

22.30

3.2

3.7

—

(3000494) Fungus identified in Specimen by Culture

806

5673

1.49

22.29

1.5

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1215

9235

1.40

22.20

4.4

3.6

225.85

467.68

ng/l

1.10

884

7104

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

283

1533

1.89

21.63

1.5

1.8

—

(3023368) Bacteria identified in Blood by Culture

1584

12625

1.35

21.44

4.5

4.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

380

2257

1.73

21.41

1.4

1.3

28.44

30.50

iu/l

0.53

320

1957

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

266

1420

1.92

21.26

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

287

1571

1.87

21.24

2.0

2.3

252.86

623.69

ug/l

1.85

265

1466

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

114

4.51

21.21

1.2

1.4

100.61

132.20

nmol/l

0.87

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

265

1420

1.91

20.94

1.3

58.92

36.79

u/ml

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

266

1434

1.90

20.64

1.2

—

(3017732) Neutrophils [#/volume] in Blood

520

3388

1.59

20.41

2.4

2.9

4.50

5.07

e9/l

0.42

405

2736

(42529406) Shigella sp [Presence] in Stool by Culture

266

1441

1.89

20.33

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

666

4590

1.51

20.29

2.4

31.73

48.34

u/l

0.94

551

3931

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1478

11738

1.35

20.26

2.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

282

1563

1.85

20.07

1.8

1.7

295.34

300.26

mu/l

0.09

255

1413

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1009

7545

1.41

20.03

3.1

2.9

3.43

2.91

e6/l

0.59

537

4009

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

825

5955

1.45

19.89

5.1

4.5

32.99

32.74

0.27

602

4046

(3023520) Reticulocytes [#/volume] in Blood

575

3860

1.54

19.78

2.4

2.5

69.00

70.20

e9/l

0.35

444

2893

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

208

1063

1.99

18.90

1.3

47.12

39.90

u/ml

0.25

121

(44816559) Phosphatidylethanol [Mass/volume] in Blood

177

853

2.11

18.87

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

203

1031

2.00

18.78

1.4

10.98

25.80

e6/l

1.39

143

794

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

203

1032

2.00

18.73

1.4

754.53

1259.49

e6/l

0.66

152

839

(3005719) IgG [Mass/volume] in Serum or Plasma

540

3618

1.54

18.71

2.5

2.7

10.02

10.51

g/l

2.23

500

3306

(3012516) Albumin [Mass/volume] in Urine

1675

13689

1.32

18.53

3.2

793.16

366.09

mg/l

1.78

1030

8556

(3025941) Bacteria identified in Stool by Culture

433

2767

1.61

18.40

1.3

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

297

1723

1.76

18.17

2.0

2.3

2.79

2.98

g/l

2.47

263

1555

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1566

12710

1.32

18.12

1.7

1.6

1.39

1.37

mmol/l

0.56

1331

10695

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

730

5235

1.45

18.11

1.8

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

240

1307

1.87

18.07

1.3

7.07

7.21

u/ml

0.02

221

(3026782) Osmolality of Urine

1216

9523

1.35

17.94

2.6

2.9

524.13

532.60

mosm/kgh2o

0.69

1008

8137

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

237

1293

1.87

17.75

1.3

6.33

5.59

u/ml

0.06

133

(3009214) Lutropin [Units/volume] in Serum or Plasma

218

1158

1.92

17.72

1.4

1.3

10.85

11.32

u/l

0.17

168

955

(40761535) Cells panel - Urine sediment

577

3969

1.50

17.65

3.8

3.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

584

4046

1.49

17.24

6.1

6.8

1.32

1.33

mmol/l

0.10

570

3949

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

523

3547

1.52

17.09

1.7

1.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

332

2.71

16.89

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

307

1836

1.71

16.87

2.0

2.3

7.15

7.47

g/l

2.61

272

1666

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

574

3981

1.49

16.84

2.6

2.3

5.13

6.91

ug/l

2.71

484

3472

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

306

1833

1.71

16.71

2.0

2.3

3.49

3.67

g/l

1.84

273

1666

(3007853) Bacteria identified in Skin by Aerobe culture

767

5629

1.42

16.69

1.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

953

7257

1.38

16.68

1.8

2.1

29.74

29.72

0.03

920

7023

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

334

2050

1.67

16.65

1.8

1.9

39.18

39.46

u/l

0.11

291

1819

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

306

1835

1.71

16.65

2.0

2.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

758

5555

1.42

16.63

2.3

2.7

5.49

7.98

umol/l

6.63

607

4804

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

721

5240

1.43

16.56

1.8

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

805

5980

1.40

16.32

8.1

6.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1042

8080

1.35

16.20

2.0

1.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

541

3746

1.49

15.98

3.2

3.7

84.71

88.96

ng/l

0.56

468

3207

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

255

1482

1.75

15.53

1.7

0.23

g/l

0.17

243

1402

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

360

2.55

15.39

1.2

38.22

40.26

mg/l

0.15

303

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1426

11638

1.30

15.38

5.4

4.9

2.20

3.22

ug/l

1.92

1286

10428

(3024666) Lithium [Moles/volume] in Serum or Plasma

254

2.86

15.21

11.9

11.2

0.66

0.61

mmol/l

0.52

231

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

284

1712

1.69

15.17

2.0

2.3

9.79

10.20

g/l

0.86

248

1527

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

416

2758

1.55

15.06

2.0

1.8

—

(3042936) Bacteria identified in Isolate by Culture

871

6637

1.37

15.05

2.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

260

1534

1.73

15.02

1.7

1.6

1.20

1.19

g/l

0.29

250

1450

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

223

1261

1.80

14.92

1.3

1.5

22.24

14.67

iu/ml

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

267

1604

1.70

14.45

1.5

1.6

251.43

301.35

titre

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1712

14409

1.27

14.26

3.9

3.8

8.74

8.89

mg/mmol

0.04

1041

8956

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

339

2173

1.60

14.21

1.9

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

712

5303

1.39

14.10

3.4

4.1

233.90

244.30

u/l

1.41

658

4988

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

349

2.49

13.84

1.1

234.13

264.27

mg/l

0.75

304

(3004716) Salmonella sp identified in Stool by Organism specific culture

372

2452

1.55

13.82

1.3

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

229

1336

1.74

13.79

1.1

2.16

5.26

u/ml

1.77

148

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

197

3.02

13.78

1.3

3.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

405

2725

1.52

13.70

1.6

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

304

2.59

13.65

1.1

7.84

11.05

nmol/l

0.14

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

393

2633

1.53

13.56

2.5

2.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

413

2799

1.51

13.50

1.8

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1154

9304

1.30

13.38

4.8

4.2

20.97

21.78

1.02

518

4491

(3041096) Erythrocytes [Presence] in Urine by Automated

1527

12755

1.27

13.38

3.6

3.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

431

2.30

13.21

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

234

1397

1.70

12.99

2.1

2.2

0.01

0.02

g/l

0.46

211

1287

(3023410) Appearance of Cerebral spinal fluid

102

465

2.22

12.64

1.6

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

239

1449

1.68

12.54

2.1

38.72

37.67

g/l

1.84

202

1278

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

187

1061

1.79

12.43

1.3

2.99

3.02

u/ml

0.01

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

283

2.56

12.42

1.5

5.30

6.64

u/l

1.15

244

(3008898) HLA-B27 [Presence]

265

1657

1.63

12.33

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

133

678

1.98

12.30

1.3

0.60

0.63

nmol/l

0.70

127

649

(3000991) Gas panel - Venous blood

525

3804

1.42

12.14

7.6

8.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

255

1586

1.64

12.13

2.2

2.3

0.41

0.93

g/l

2.88

223

1376

(3009466) Valproate [Moles/volume] in Serum or Plasma

128

650

1.99

11.98

5.9

5.2

377.03

363.65

umol/l

0.55

116

569

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

330

2188

1.54

11.96

3.8

4.0

24.52

24.21

mmol/l

1.09

323

2144

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

120

598

2.03

11.84

1.3

—

nmol/l

—

(3016018) Differential panel - Cerebral spinal fluid

106

506

2.12

11.73

1.5

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

214

1289

1.69

11.53

2.2

0.00

g/l

-0.00

192

1201

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

217

1315

1.68

11.43

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

216

1308

1.68

11.41

2.2

0.00

g/l

0.50

194

1203

(3023183) Ammonium ion [Moles/volume] in Plasma

165

931

1.80

11.21

2.9

2.8

33.63

35.11

umol/l

0.33

150

840

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

131

687

1.93

11.20

1.3

0.57

0.32

nmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

122

625

1.97

11.17

1.3

—

(3003396) Base excess in Arterial blood by calculation

691

5307

1.34

11.16

6.2

7.2

1.10

1.13

mmol/l

0.07

567

4183

(3024869) Neuronal Ab [Presence] in Serum

4.07

11.11

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

171

979

1.77

11.07

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

171

979

1.77

11.07

1.4

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

200

1204

1.69

10.82

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

410

2900

1.45

10.82

7.9

8.9

93.97

94.01

0.05

410

2890

(3006653) Thiamine [Moles/volume] in Blood

232

2.60

10.75

1.3

138.89

134.71

nmol/l

0.33

232

(3027801) Oxygen [Partial pressure] in Arterial blood

689

5318

1.34

10.74

6.3

7.2

11.93

12.46

kpa

2.05

659

5058

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

689

5320

1.34

10.72

6.3

7.2

5.13

5.09

kpa

0.54

659

5059

(3016502) Oxygen saturation in Arterial blood

620

4724

1.35

10.53

6.6

7.6

95.82

95.78

0.07

602

4534

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

205

1252

1.66

10.51

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

122

643

1.92

10.31

1.3

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

843

6733

1.30

10.25

3.4

3.0

0.67

0.77

ug/l

1.09

575

4473

(3035637) Corticotropin [Mass/volume] in Plasma

113

582

1.96

10.22

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

274

2.43

10.22

1.6

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

185

1109

1.69

10.19

1.3

1.4

—

(3049717) Cytology report of Urine Cyto stain

253

1642

1.57

10.12

2.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

626

4815

1.34

9.97

2.5

2.0

—

(3020891) Body temperature

276

1838

1.53

9.84

5.0

4.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

119

635

1.89

9.71

1.3

52.26

48.30

u/ml

—

(3042517) Benzodiazepines panel - Urine

5.01

9.56

2.5

2.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

285

2.33

9.40

1.1

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

562

4292

1.34

9.38

2.4

1.9

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

117

631

1.87

9.26

1.3

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

530

4028

1.35

9.14

3.3

3.8

1.22

1.23

mmol/l

1.25

439

3511

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

112

599

1.89

9.11

2.0

2.1

16.44

23.24

mg/l

0.84

148

(3024522) Salmonella sp identified in Specimen by Organism specific culture

117

635

1.86

9.09

1.3

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

266

2.35

8.98

1.4

169.28

196.20

pmol/l

0.32

266

(4034850) Laboratory test

238

1568

1.54

8.95

12.3

9.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

679

5368

1.30

8.86

1.6

1.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

569

4398

1.33

8.75

6.8

8.0

121.46

121.06

g/l

0.19

555

4268

(3028026) IgM [Mass/volume] in Serum or Plasma

390

2845

1.40

8.68

1.9

1.41

1.35

g/l

0.17

356

2604

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

286

1974

1.47

8.61

2.1

1.9

—

(3012544) pH of Venous blood

568

4405

1.32

8.53

4.0

3.7

7.40

7.39

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

148

882

1.70

8.40

1.2

1.1

2.07

2.22

u/ml

0.06

438

(4094501) Cardiovascular stress test using bicycle ergometer

199

1281

1.57

8.31

1.1

—

(3019060) Gas panel - Arterial blood

413

3067

1.37

8.26

4.1

5.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

264

2.29

8.23

1.1

1.03

1.11

u/l

0.82

132

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

300

2110

1.45

8.20

1.7

1.46

1.55

g/l

1.00

257

1807

(3025468) Yersinia sp identified in Specimen by Organism specific culture

113

628

1.82

8.18

1.3

1.4

—

(40761536) Microorganisms panel - Urine sediment

531

4103

1.32

8.18

4.2

4.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

669

5334

1.29

8.17

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

113

629

1.81

8.14

1.3

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

264

1816

1.48

8.11

1.9

1.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

487

3722

1.34

8.09

3.5

4.0

0.53

0.65

0.72

139

1208

(3003888) Timothy IgE Ab [Units/volume] in Serum

134

786

1.72

8.08

1.1

6.62

5.28

u/ml

0.30

395

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

119

675

1.78

8.06

1.1

2.66

2.75

u/ml

0.02

299

(3037121) Protein [Mass/volume] in Urine

241

1630

1.50

8.05

3.2

3.0

0.27

0.31

g/l

0.39

644

(3005988) Vibrio sp identified in Specimen by Organism specific culture

113

632

1.80

8.02

1.3

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

504

3878

1.33

7.99

3.7

4.2

0.21

0.10

0.94

134

1201

(3010726) Horse dander IgE Ab [Units/volume] in Serum

122

701

1.76

7.92

1.1

1.45

1.41

u/ml

0.02

332

(3021447) Carbon dioxide [Partial pressure] in Venous blood

546

4259

1.31

7.86

4.1

3.7

5.89

5.83

kpa

0.62

529

4135

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

197

1283

1.55

7.84

1.9

2.0

10.84

11.46

mg/l

0.46

183

1185

(3024139) IgG subclass 3 [Mass/volume] in Serum

486

1.91

7.83

1.7

1.3

0.36

0.42

g/l

1.07

335

(3028192) IgG subclass 2 [Mass/volume] in Serum

486

1.91

7.83

1.7

1.3

2.73

2.85

g/l

0.27

337

(3002032) Base excess in Venous blood by calculation

543

4235

1.31

7.82

4.1

3.7

1.97

mmol/l

0.00

481

3608

(3006184) Hemoglobin [Mass/volume] in Capillary blood

166

1040

1.61

7.80

2.0

2.2

131.65

128.04

g/l

1.08

112

744

(3027135) IgG subclass 1 [Mass/volume] in Serum

487

1.90

7.78

1.7

1.3

5.68

6.92

g/l

4.29

335

(3025159) Blasts/100 leukocytes in Blood

479

3674

1.33

7.77

3.7

4.2

0.04

0.39

1.57

113

1001

(3017181) Myelocytes/100 leukocytes in Blood

524

4071

1.32

7.76

3.7

4.1

1.02

0.88

0.50

153

1391

(3020779) Urea [Moles/volume] in Serum or Plasma

525

4085

1.31

7.69

6.5

7.4

9.70

9.71

mmol/l

0.01

502

3897

(3014133) Dog dander IgE Ab [Units/volume] in Serum

108

604

1.80

7.69

1.1

4.28

2.98

u/ml

0.31

279

(3023430) Cat dander IgE Ab [Units/volume] in Serum

101

558

1.82

7.49

1.1

7.02

3.88

u/ml

0.51

213

(3038177) Helicobacter pylori Ab [Presence] in Serum

133

796

1.69

7.48

1.4

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

217

1459

1.51

7.48

3.2

3.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

530

1.84

7.46

1.5

26.29

24.35

iu/ml

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

100

552

1.83

7.44

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

125

737

1.71

7.43

1.1

5.78

15.20

au/ml

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

147

910

1.63

7.27

1.1

1.2

—

215.00

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

124

736

1.70

7.21

1.2

38.70

40.01

u/l

0.02

106

639

(3001019) Free T4 and TSH panel - Serum or Plasma

346

2555

1.38

7.19

1.9

1.7

—

(3003338) MCHC [Mass/volume]

4264

40711

1.19

7.14

23.2

18.1

331.89

331.95

g/l

0.20

4251

40421

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

218

2.31

7.06

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

126

756

1.68

7.05

1.1

1.08

1.16

u/ml

0.05

309

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

176

2.45

6.98

1.1

4171.00

480.39

ng/l

—

(4062490) Immunoglobulin typing, IgG

488

1.84

6.80

1.7

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

203

2.33

6.80

1.1

1.6

28.57

29.58

umol/l

0.26

197

(3036180) Methadone [Presence] in Urine

185

2.39

6.76

2.7

2.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

506

3993

1.29

6.69

2.7

2.9

167.96

190.31

ng/l

0.83

458

3627

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

316

2.04

6.66

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

566

4535

1.28

6.63

2.1

2.2

0.22

0.21

g/l

2.59

533

4236

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

219

1519

1.46

6.51

2.4

2.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

312

2.03

6.51

1.3

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

449

3500

1.31

6.51

3.4

3.1

4.62

4.59

kpa

0.12

431

3385

(3024980) IgG subclass 4 [Mass/volume] in Serum

126

773

1.64

6.50

1.8

1.6

0.64

0.76

g/l

0.90

102

579

(3011985) Renin [Units/volume] in Plasma

105

614

1.72

6.48

1.4

1.5

83.54

46.78

mu/l

0.93

538

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

314

2.02

6.41

1.0

264.40

337.51

ng/l

2.79

209

(3026389) Candida sp identified in Specimen by Organism specific culture

118

716

1.66

6.36

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

501

1.79

6.28

1.1

0.06

0.26

u/ml

1.80

140

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

366

2799

1.33

6.10

6.5

7.1

24.98

24.89

mmol/l

0.19

359

2780

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

602

4911

1.25

6.06

3.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

131

829

1.59

6.00

1.4

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

316

1.97

5.95

1.0

815.72

722.17

ng/l

0.77

205

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

539

4354

1.26

5.91

1.3

1.4

—

(40768443) Skin Pathology biopsy report

294

2189

1.36

5.86

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

318

1.96

5.85

1.0

36.73

45.09

ng/l

1.49

209

(43055514) Macroprolactin [Presence] in Serum or Plasma

102

2.75

5.78

1.4

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

168

2.33

5.73

1.0

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

377

1.87

5.73

1.3

2.02

2.08

mmol/l

0.19

354

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

319

2414

1.34

5.73

8.2

9.2

24.38

24.35

mmol/l

0.06

309

2343

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

122

769

1.60

5.70

1.3

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

181

1248

1.47

5.60

1.7

1.9

4.09

4.64

iu/l

0.31

459

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

139

2.45

5.60

1.4

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

108

664

1.64

5.59

1.3

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

375

2926

1.30

5.43

6.3

7.0

24.85

24.58

mmol/l

0.76

360

2773

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

806

6856

1.20

5.42

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

273

1.99

5.34

1.5

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

490

1.72

5.31

1.1

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

240

2.05

5.29

1.1

1.3

190.98

337.74

u/l

1.53

219

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

309

1.92

5.28

1.1

12.15

10.39

iu/ml

0.08

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.98

5.25

1.2

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

255

2.01

5.21

1.1

1.5

6.29

8.12

ug/l

0.62

222

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

375

1.82

5.20

1.1

1.0

287.84

291.83

mg/l

0.17

337

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

215

2.10

5.19

1.1

2.23

5.31

u/ml

—

(4146454) Self-monitoring of blood glucose

501

1.71

5.18

2.8

2.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

157

2.30

5.17

1.4

71.42

124.99

nmol/24h

0.68

157

(3021879) Hepatitis B virus core Ab [Presence] in Serum

431

3447

1.27

5.16

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

517

1.69

5.15

1.1

1.2

56.49

64.21

u/l

0.78

474

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

122

791

1.55

5.10

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

171

2.23

5.08

1.3

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

337

1.85

4.98

1.2

1.3

1.98

1.45

u/ml

0.26

184

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

109

693

1.58

4.97

1.4

1.5

0.35

0.38

nmol/l

0.17

537

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

316

1.88

4.96

2.4

469.28

512.40

e6/l

0.31

260

(3044927) Protein electrophoresis panel - Urine

470

1.71

4.96

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

509

1.68

4.91

3.4

5.2

7.32

7.41

mmol/l

0.08

427

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

157

1083

1.46

4.90

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

442

1.73

4.89

2.7

2.9

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

572

1.64

4.86

1.4

1.3

295.41

318.29

pmol/l

0.26

492

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.64

4.81

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

196

1414

1.40

4.80

1.4

1.3

—

(3023419) Bacteria identified in Sputum by Culture

110

707

1.57

4.80

2.8

2.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

229

2.02

4.79

2.0

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

488

3997

1.24

4.77

1.8

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

106

678

1.57

4.73

1.1

—

(3045414) Leukocytes [Presence] in Urine

289

2223

1.32

4.69

1.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

107

689

1.56

4.64

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

968

8483

1.17

4.58

1.5

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

261

1.92

4.57

1.3

1.5

27.50

23.94

umol/l

0.31

247

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

126

845

1.50

4.55

1.3

1.4

118.20

114.86

u/ml

0.12

173

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

111

2.44

4.45

1.0

1.1

1038.21

302.46

pmol/l

0.42

(3032057) Clostridioides difficile [Presence] in Stool

2.53

4.45

1.8

2.0

—

(3012501) Base excess in Blood by calculation

152

1065

1.44

4.41

3.6

4.3

2.42

2.67

mmol/l

0.64

101

732

(3013290) Carbon dioxide [Partial pressure] in Blood

152

1066

1.44

4.39

3.6

4.3

5.07

5.02

kpa

0.45

146

1048

(3004616) Nuclear Ab [Presence] in Serum

612

1.58

4.37

1.3

—

(3002256) Pathology report gross observation

742

6387

1.19

4.36

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

382

1.74

4.36

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

382

1.74

4.36

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

137

946

1.46

4.30

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

152

1073

1.43

4.25

3.6

4.4

8.87

8.53

kpa

1.59

146

1054

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

119

801

1.50

4.25

1.0

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

196

1446

1.37

4.24

2.3

3.3

1.30

2.03

ratio

0.95

116

(3029075) Extractable nuclear Ab panel - Serum

139

2.24

4.23

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

378

1.73

4.23

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

105

689

1.53

4.23

1.1

—

(3051651) Icteric interference index of Serum or Plasma

290

1.84

4.23

2.7

3.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

1204

0.62

4.21

4.7

4.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

379

1.72

4.20

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

201

1492

1.36

4.19

2.2

3.3

39.18

94.90

mg/l

0.83

170

1206

(3010838) Calcium [Moles/time] in 24 hour Urine

130

896

1.46

4.14

1.8

1.9

4.84

5.00

mmol/24h

0.25

114

783

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

382

1.71

4.09

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

244

1.89

4.05

1.2

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

200

1492

1.35

4.05

2.3

3.3

30.44

55.53

mg/l

1.84

170

1205

(3000060) B lymphocytes [#/volume] in Blood

123

2.28

4.02

2.9

1.9

273.16

142.38

e6/l

0.71

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

130

2.24

3.98

1.0

1.1

13.33

12.06

u/ml

0.06

(40759836) Histone Ab [Presence] in Serum by Immunoblot

378

1.70

3.97

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

109

732

1.50

3.96

1.2

1.4

30.76

29.45

u/l

0.12

593

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

188

1396

1.36

3.93

1.4

1.3

—

(3010421) pH of Blood

171

1255

1.37

3.85

3.7

4.2

7.42

0.35

158

1141

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.60

3.80

2.1

2.0

14.05

16.72

umol/l

0.63

(3002079) Sodium [Moles/time] in 24 hour Urine

194

1.97

3.76

1.2

1.3

165.77

152.18

mmol/24h

0.56

194

(3051611) Lipemic interference index of Serum or Plasma

503

1.58

3.68

2.8

3.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

297

2372

1.27

3.68

2.5

2.7

0.26

0.28

e6/l

0.13

287

2303

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

210

1.91

3.66

2.1

2.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

133

945

1.42

3.64

1.3

1.4

—

(3011412) CD3 cells [#/volume] in Blood

465

1.60

3.64

2.3

1.27

1.18

e9/l

0.44

414

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

465

3904

1.21

3.62

2.5

2.6

67.23

65.83

ml/min/173m2

0.36

194

1555

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.01

3.59

1.1

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

619

1.51

3.57

1.1

1.48

1.50

g/l

0.25

559

(3000093) Morphology [Interpretation] in Blood Narrative

424

1.61

3.47

1.2

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

194

1479

1.32

3.45

1.6

1.5

0.27

4.92

iu/ml

0.66

323

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

449

1.59

3.43

1.7

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

296

1.73

3.41

1.1

1.2

61.66

84.09

u/l

2.60

260

(3006442) Creatine [Moles/volume] in Serum or Plasma

312

1.71

3.38

1.9

1.5

77.23

78.61

umol/l

0.14

312

(3022621) pH of Urine by Test strip

386

3207

1.22

3.36

3.4

3.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

290

1.73

3.36

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

168

1263

1.34

3.30

1.4

—

(1616796) Gas panel - Central venous blood

142

1040

1.37

3.30

3.6

3.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

378

1.62

3.22

1.2

70.00

173.51

titre

—

(3024928) Oxygen saturation in Venous blood

133

968

1.38

3.22

2.6

2.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

104

725

1.44

3.21

1.2

1.1

27.18

13717.70

iu/ml

0.54

171

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

228

1.80

3.19

1.7

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

228

1.80

3.19

1.7

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.63

3.13

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.54

3.12

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

312

1.67

3.12

1.4

1.6

7.37

6.35

u/l

0.21

262

(3036489) Thrombin time

223

1759

1.28

3.11

1.6

2.0

21.00

21.45

0.92

201

1528

(3003181) Sodium [Moles/volume] in Urine

116

831

1.40

3.09

1.2

1.4

67.10

62.70

mmol/l

0.50

672

(3007463) Buprenorphine [Presence] in Urine

5.01

3.05

5.5

5.1

—

(3015183) Erythrocyte sedimentation rate

239

1.76

3.04

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

218

1.79

3.00

6.4

12.2

—

(3028717) Thiamine [Mass/volume] in Blood

2.75

2.98

1.0

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

173

1329

1.31

2.96

1.2

48.00

159.82

titre

—

112

(44813793) Dust mix specific IgE antibody measurement

333

1.63

2.94

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

287

1.68

2.94

1.1

1.2

13.45

20.96

u/l

1.37

247

(40767503) Oxygen content in Capillary blood by calculation

135

1002

1.36

2.92

2.7

2.5

17.00

16.13

1.65

500

(3021901) Oxygen saturation in Capillary blood

114

824

1.39

2.91

2.9

2.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

146

1098

1.34

2.90

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.44

2.89

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

258

1.71

2.89

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.70

2.88

1.0

—

(3014271) Vancomycin [Susceptibility]

244

1.73

2.86

3.1

2.9

—

(3045424) Erythrocytes [Presence] in Urine

113

821

1.38

2.81

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

206

1633

1.27

2.79

2.7

2.1

3465.64

5072.76

u/l

0.50

656

(3015076) Soybean IgE Ab [Units/volume] in Serum

239

1.72

2.76

1.0

1.1

0.89

1.51

u/ml

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

159

1.89

2.74

2.9

2.6

25.81

29.40

umol/l

0.72

111

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

177

1382

1.29

2.72

1.7

2.6

3.52

3.60

g/l

0.28

168

1307

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

396

1.55

2.71

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

396

1.55

2.71

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

396

1.55

2.71

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

966

0.67

2.69

3.5

3.2

6.69

7.47

mmol/l

2.28

942

(3006270) Folate [Moles/volume] in Blood

429

1.52

2.68

1.2

1.1

342.33

364.41

nmol/l

0.41

373

(3042631) Mycobacterium sp identified in Specimen

619

1.43

2.65

2.7

2.9

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

273

1.65

2.64

1.0

1.1

6.75

1.04

u/ml

—

(3000475) Leukocytes [#/volume] in Synovial fluid

149

1143

1.31

2.62

1.7

1.6

10706.97

11890.22

e6/l

0.16

118

822

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.66

2.62

2.2

1.6

37.23

42.39

umol/l

0.35

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

630

1.42

2.60

1.7

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

102

742

1.38

2.55

1.3

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

102

742

1.38

2.55

1.3

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.23

2.51

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

121

907

1.34

2.51

2.1

2.0

0.80

0.82

nmol/l

0.12

763

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.16

2.50

1.7

1.6

132.86

119.22

ng/l

0.10

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

194

1.76

2.49

1.4

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

220

1784

1.24

2.49

1.5

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

248

1.66

2.45

1.0

1.1

70.67

79.16

u/l

0.65

231

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

579

1.42

2.44

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

1028

0.70

2.44

3.3

3.1

1.55

1.56

mmol/l

0.02

998

(3021788) Differential panel - Synovial fluid

114

851

1.35

2.44

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

103

2.04

2.41

1.2

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

400

1.51

2.40

1.5

1.3

1.38

1.48

nmol/l

0.28

364

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

353

1.53

2.37

2.4

2.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

353

1.53

2.37

1.4

1.5

1.47

1.16

promille

0.77

269

(1761868) Lipid panel - Serum or Plasma

1782

16791

1.09

2.33

2.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

110

824

1.34

2.32

1.5

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

300

1.57

2.29

1.6

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

175

1398

1.26

2.29

1.1

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

538

1.42

2.26

1.4

2.1

6.74

8.06

umol/l

0.27

389

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

119

906

1.32

2.26

1.1

1.2

324.08

275.85

u/ml

0.53

555

(40760888) Immunoglobulin light chains.free panel - Serum

143

1117

1.29

2.25

2.0

3.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

106

794

1.34

2.25

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

193

1564

1.24

2.24

2.4

3.2

0.34

0.35

u/ml

0.09

899

(3020874) Milk IgE Ab [Units/volume] in Serum

272

1.59

2.19

1.1

1.0

16.62

2.42

u/ml

0.39

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

223

1841

1.22

2.18

2.0

0.91

2.05

ug/l

2.73

195

1625

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

627

1.38

2.17

1.4

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.02

2.15

1.1

1.3

0.52

99.45

mg/l

0.80

(3008757) Leukocyte morphology finding [Identifier] in Blood

510

1.42

2.15

3.3

3.8

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

4.29

2.15

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

308

1.53

2.07

1.6

1.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.91

2.07

3.7

8.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

439

1.44

2.07

4.5

3.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

398

1.46

2.06

1.1

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

125

973

1.29

2.05

2.7

3.7

57.13

57.27

0.05

125

973

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

4.00

2.04

1.0

—

(3048879) Bone marrow aspiration report

125

1.84

2.02

1.2

1.9

—

(37021550) Renin [Units/volume] in Plasma --upright

104

1.93

2.00

1.2

1.3

93.56

67.21

mu/l

0.16

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

570

1.37

1.97

1.6

45.48

58.96

1.80

354

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

166

1345

1.24

1.97

1.8

2.4

192.12

191.20

0.04

158

1279

(3003129) Base excess in Capillary blood by calculation

119

1.85

1.96

1.1

1.8

0.50

1.10

mmol/l

0.30

111

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.19

1.94

1.1

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

521

1.39

1.94

2.3

2.0

16.75

24.40

ug/l

1.70

514

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

480

1.40

1.91

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

531

1.38

1.91

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

748

1.32

1.88

1.2

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.16

1.87

1.1

1.2

124.11

69.33

ng/l

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

499

1.39

1.87

1.5

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

457

1.40

1.87

1.5

1.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.86

1.86

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

107

1.87

1.85

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

107

1.87

1.85

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

107

1.87

1.85

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

107

1.87

1.85

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

221

1.59

1.84

1.1

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

229

1.58

1.84

1.4

1.5

1.00

3.59

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.05

1.80

7.1

4.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

135

1082

1.25

1.79

1.5

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.76

1.79

2.0

3.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.76

1.79

1.1

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

135

1083

1.25

1.78

1.5

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

815

0.72

1.74

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

209

1.58

1.73

1.3

2.3

114.93

141.97

umol/l

0.25

114

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.92

1.72

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

516

1.36

1.72

1.1

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

516

1.36

1.72

1.1

1.4

—

(3005033) Fetal Nuchal fold Thickness US

812

0.72

1.71

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

218

1.56

1.70

4.7

4.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.06

1.70

1.9

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

121

965

1.26

1.69

1.1

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

291

1.48

1.69

1.7

1.4

—

(3017509) Phencyclidine [Presence] in Urine

2.50

1.66

3.3

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

115

914

1.26

1.66

1.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

134

1.72

1.65

1.0

1.1

9.85

1.89

u/ml

0.57

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.10

1.65

1.8

2.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

120

1.75

1.61

1.0

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.84

1.61

1.8

2.2

8.13

7.48

mmol/l

0.20

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.15

1.61

1.0

1.1

—

(3012565) Volume of 24 hour Urine

238

1.52

1.59

1.9

2.4

1852.40

1887.70

0.07

215

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

121

1.74

1.58

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

561

1.32

1.54

2.2

31.96

32.54

0.53

556

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

224

1.52

1.53

1.6

4.14

6.61

nmol/l

0.43

179

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.34

1.52

1.2

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.16

1.50

1.0

1.1

1.60

1.68

umol/24h

0.15

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.16

1.50

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

409

1.37

1.49

1.0

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

384

1.38

1.48

2.0

2.2

43.85

39.99

1.18

377

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

178

1.58

1.48

1.0

1.2

0.31

0.30

g/l

0.35

143

(3030313) Adrenal Ab [Titer] in Serum

2.43

1.47

1.0

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.84

1.45

1.1

1.5

—

97.88

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.13

1.44

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

840

0.76

1.41

1.4

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

100

801

1.25

1.40

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

197

1.53

1.39

1.2

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

160

1346

1.19

1.39

2.0

1.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

616

1.29

1.38

5.1

6.6

11.97

11.90

mg/l

0.06

574

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

803

1.25

1.37

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

993

0.78

1.37

1.4

—

(3020491) Glucose [Moles/volume] in Blood

348

1.38

1.36

2.4

2.2

6.61

6.66

mmol/l

0.06

230

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

992

0.78

1.36

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

992

0.78

1.36

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

990

0.78

1.34

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.04

1.32

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

350

1.37

1.32

4.4

2.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

333

1.38

1.32

1.6

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

701

1.26

1.31

1.4

—

(21494755) Public health laboratory ask at order entry panel

392

4333

0.90

1.29

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.35

1.29

1.3

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

251

2210

1.14

1.26

4.0

3.3

25.38

25.34

mmol/l

0.10

245

2144

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.40

1.24

1.0

1.1

9.52

8.37

mmol/l

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.22

1.24

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

139

1.58

1.23

2.2

3.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

147

1.57

1.22

1.2

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

572

0.73

1.22

2.5

2.4

106.24

105.26

mmol/l

0.83

564

(3041354) Potassium [Moles/volume] in Venous blood

572

0.73

1.22

2.5

2.4

3.96

4.04

mmol/l

0.53

564

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

180

1.50

1.20

2.4

2.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

213

0.56

1.19

1.6

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

170

1462

1.17

1.19

1.6

2.2

92.23

92.35

0.02

163

1404

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

2.31

1.18

1.0

1.27

5.69

u/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.88

1.18

1.3

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.88

1.18

1.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.50

1.15

1.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

312

2811

1.12

1.11

3.3

3.1

131.23

128.62

g/l

1.32

305

2736

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

896

0.80

1.09

1.4

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

719

1.23

1.09

1.3

1.2

5.54

4.51

u/ml

0.33

308

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.38

1.09

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

153

1316

1.17

1.09

2.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

559

0.75

1.08

2.5

2.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

338

1.33

1.07

1.0

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

111

932

1.19

1.05

3.7

5.2

2308.67

572.66

iu/ml

0.48

127

(3019230) Fractional oxyhemoglobin in Venous blood

804

1.21

1.05

2.8

2.5

64.86

63.33

0.30

799

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.12

1.05

1.7

1.5

2.90

2.03

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.12

1.05

1.7

1.5

2.10

4.28

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.12

1.05

1.7

1.5

4.21

1.64

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.12

1.05

1.7

1.5

0.55

1.16

mg/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

262

1.38

1.05

1.2

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

178

1.46

1.05

1.2

1.5

13.71

15.16

pmol/l

0.74

152

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.79

1.04

1.2

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

116

980

1.19

1.03

1.6

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.27

1.03

1.0

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

160

1839

0.87

1.03

1.4

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

229

1.40

1.03

1.8

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

229

1.40

1.03

1.8

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.63

1.03

1.2

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

473

1.27

1.02

3.0

3.2

60.76

56.75

0.78

405

(3033923) Metanephrine [Moles/time] in 24 hour Urine

106

1.61

1.02

1.0

1.1

0.72

0.68

umol/24h

0.14

(3041806) Other cells [#/volume] in Blood by Manual count

122

1.56

1.02

1.3

1.5

—

(3004451) EKG impression Narrative

230

1.39

1.01

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

448

1.28

1.00

1.5

1.4

100024.42

70538.43

e6/l

0.15

303

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

457

1.27

1.00

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.80

0.98

1.4

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

424

0.73

0.97

1.1

1.0

—

(3017704) Immunofixation for Urine

258

1.36

0.96

1.1

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

310

1.32

0.96

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

740

1.21

0.96

1.3

1.2

1.81

3.78

u/ml

1.99

241

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

133

1.51

0.94

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

125

1.52

0.93

1.3

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

312

1.32

0.93

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.82

0.92

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.82

0.92

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.82

0.92

1.0

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

280

2541

1.11

0.91

9.0

9.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

608

1.22

0.91

1.5

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

366

1.29

0.91

1.7

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

107

913

1.18

0.88

2.5

2.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

119

1.51

0.88

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

675

1.20

0.87

1.9

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

512

1.23

0.87

1.6

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

186

1.40

0.87

1.9

2.0

47.02

58.65

ug/l

0.78

180

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.00

0.87

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

486

1.24

0.85

1.4

2.0

—

(3016038) Potassium [Moles/volume] in Urine

317

1.30

0.85

1.0

1.2

29.67

34.76

mmol/l

1.07

272

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1072

0.85

0.84

1.4

1.5

—

(3008295) Osmolality of Serum or Plasma

505

1.23

0.84

1.5

1.4

284.42

277.66

mosm/kgh2o

1.36

384

(3022475) Manganese [Moles/volume] in Blood

1.94

0.84

1.0

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

491

0.77

0.84

1.1

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

137

1.46

0.83

1.2

1.1

—

(3024471) HLA-A [Type]

139

0.57

0.83

1.1

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

635

1.20

0.81

1.5

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

105

1.53

0.81

1.1

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

258

1.32

0.81

1.6

1.4

1.45

1.22

nmol/l

0.35

204

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

392

1.25

0.79

1.1

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

207

1.35

0.79

1.4

1.3

27.31

31.96

nmol/l

0.44

180

(4212803) Bone marrow aspirate examination

1.67

0.78

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.67

0.78

1.8

2.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

150

0.60

0.78

1.2

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

122

1066

1.15

0.77

2.1

2.3

108.44

91.06

ug/min

0.22

632

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.77

0.76

1.2

1.0

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.77

0.76

1.3

1.2

—

2.17

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

261

1.30

0.76

1.8

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

201

1.34

0.74

1.6

2.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

478

1.22

0.73

4.2

5.0

121.49

59.86

u/ml

0.30

135

(3003694) ABO and Rh group [Type] in Blood

1355

13103

1.04

0.73

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

140

1241

1.13

0.73

1.3

—

(40768806) Pleura Pathology biopsy report

469

0.79

0.73

1.6

—

(3024932) HLA-DR beta [Type]

136

0.59

0.72

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

2.00

0.72

1.2

1.0

0.36

0.63

u/ml

—

(3000330) Specific gravity of Urine by Test strip

225

2462

0.91

0.70

3.2

3.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

160

1.38

0.70

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.71

0.70

3.0

2.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.55

0.69

1.7

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

228

0.70

0.69

2.9

1.5

—

(3028433) Virus identified in Specimen by Culture

152

1.38

0.69

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

231

1.30

0.67

1.3

1.1

15.60

21.60

u/ml

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

238

0.71

0.67

1.4

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.63

0.66

1.0

1.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

184

1669

1.11

0.66

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

259

1.28

0.65

1.8

1.6

—

(3047189) Immunofixation for 24 hour Urine

225

0.71

0.65

1.8

1.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.59

0.65

1.0

1.2

8.71

17.32

u/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.57

0.65

1.8

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

233

1.29

0.64

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

233

1.29

0.64

1.4

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

157

1738

0.90

0.64

3.0

3.4

154.60

3241.50

u/ml

1.19

136

1473

(21494434) Karyotype in Bone marrow

395

1.22

0.64

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.72

0.64

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.72

0.64

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

281

0.75

0.63

1.1

—

(3025130) Human papilloma virus identified in Specimen

681

1.16

0.63

1.8

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

207

1.31

0.63

1.1

1915.70

1517.75

miu/ml

0.91

207

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.46

0.61

1.8

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

740

1.15

0.61

2.2

2.6

88.20

1301.14

u/ml

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

130

1.39

0.61

1.1

—

(3047181) Lactate [Moles/volume] in Blood

167

1517

1.10

0.60

4.8

6.4

1.33

1.28

mmol/l

0.15

151

1331

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

1.4

—

1.48

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

333

0.78

0.59

1.7

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.51

0.58

1.8

2.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

437

1.19

0.58

1.5

34.05

31.49

0.17

262

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

158

1.33

0.57

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

132

1.36

0.57

1.1

—

(3000012) Reticulocyte production index

633

1.16

0.56

2.1

2.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

517

0.83

0.56

2.1

2.4

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

1.62

0.55

1.0

0.01

0.93

u/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.46

0.54

1.2

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.48

0.53

1.1

—

(3044941) Cell count panel - Synovial fluid

760

1.13

0.52

1.4

—

(3037756) Immunofixation for Serum or Plasma

109

979

1.12

0.51

1.4

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

110

1222

0.90

0.51

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.41

0.51

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

790

1.13

0.51

1.4

1.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

135

1.33

0.51

1.2

1.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

607

0.86

0.50

3.2

2.6

13.07

13.18

0.38

600

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.49

0.49

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.49

0.49

1.2

1.1

53.68

43.97

mg/l

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

307

1.21

0.49

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.56

0.49

3.3

2.6

0.29

0.67

u/field

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.56

0.49

1.1

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

1.52

0.48

1.4

1.2

—

(3019174) dRVVT (LA screen)

1.49

0.47

1.4

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.49

0.47

1.3

—

640.53

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

272

1.21

0.47

1.3

5.42

5.81

mmol/l

1.55

261

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

458

1.16

0.46

1.2

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

287

0.80

0.45

1.4

1.3

1.53

1.59

g/l

0.49

287

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

133

1218

1.09

0.45

3.3

3.2

1.50

1.52

mg/l

0.12

118

1122

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

157

1449

1.09

0.45

1.3

257.12

222.36

miu/ml

0.59

682

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

210

1.24

0.45

1.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

567

0.86

0.44

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

1.37

0.43

1.5

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.61

0.43

1.4

2.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

239

1.21

0.42

1.8

2.39

3.36

u/field

0.31

167

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.64

0.42

2.3

7.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

140

1.29

0.41

1.9

1.5

8.82

8.72

ug/l

0.03

140

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.43

0.41

4.7

5.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

167

1.26

0.41

1.0

1.1

—

(40760409) HLA-A [Type] by High resolution

0.00

0.41

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.41

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.41

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.41

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

231

1.21

0.41

1.2

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.36

0.41

1.0

—

(3013862) HLA-DP [Type]

0.00

0.40

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.40

0.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

250

1.20

0.40

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

183

1956

0.93

0.40

4.5

5.4

0.89

0.00

171

1825

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.31

0.39

1.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

357

0.84

0.39

2.0

2.3

575.14

626.07

0.34

235

(40768795) Lymph node Pathology biopsy report

484

1.14

0.39

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

115

1.31

0.38

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

355

0.84

0.37

1.9

1.5

0.98

0.96

g/l

0.11

355

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

188

1.22

0.37

2.9

2.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

112

0.71

0.37

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

662

0.89

0.37

1.3

1.5

—

(3006462) Nitrate [Presence] in Urine

226

1.20

0.35

3.2

3.6

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

498

1.13

0.35

2.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

117

1.28

0.35

1.3

1.2

—

(3035880) pH of Pleural fluid

244

0.82

0.34

1.2

1.3

—

(3011648) Oxygen content in Venous blood

377

1.14

0.34

1.9

2.2

11.35

11.06

0.15

377

(3032868) Hemoglobin electrophoresis panel in Blood

1.33

0.33

1.2

1.5

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

100

1.30

0.33

1.1

1.3

106.46

109.71

0.12

(3051387) C reactive protein [Mass/volume] in Capillary blood

110

1018

1.08

0.33

5.1

3.4

21.09

26.63

mg/l

1.17

617

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

146

1.23

0.32

1.9

2.0

37117.25

21118.25

e6/l

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

186

1967

0.94

0.32

4.5

5.3

1.63

1.64

0.01

174

1831

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

211

1.19

0.31

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.30

1.3

1.1

—

(40768793) Breast Pathology biopsy report

135

1265

1.07

0.30

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.31

0.30

1.3

1.2

2.72

1.77

mmol/l

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.25

0.29

1.0

1.4

78.89

74.36

—

(3023199) Leukocytes [#/volume] in Pleural fluid

535

0.90

0.29

1.4

1.5

5817.95

1911.44

e6/l

0.79

385

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

109

0.73

0.29

2.9

7.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.29

0.28

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.29

0.28

12.6

12.5

9.09

5.69

mmol/l

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

365

1.12

0.27

1.5

21.60

20.36

u/ml

—

(40765096) Chromosome analysis panel by Banding

138

0.80

0.25

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.23

0.25

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.23

0.25

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.23

0.25

1.1

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

254

1.14

0.25

3.0

2.7

44.86

42.93

0.27

146

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

292

1.13

0.25

1.1

1.03

1.05

ratio

0.58

101

(40762365) Oxygen content in Arterial blood by calculation

1.20

0.25

2.9

2.5

14.73

14.85

ml/dl

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.28

0.24

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.32

0.23

1.0

1.2

—

(3033799) Differential panel - Peritoneal fluid

143

1.19

0.23

2.9

2.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

284

2744

1.04

0.23

1.5

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

776

1.07

0.22

2.7

3.3

1.24

1.53

0.44

693

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

515

1.09

0.22

1.2

1.4

2.48

3.80

ug/l

1.21

447

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

295

1.12

0.22

1.8

1.5

—

(3019977) pH of Arterial blood

257

1.13

0.22

1.8

3.2

7.43

7.42

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

1.9

—

(3013727) Leukocytes other/100 leukocytes in Blood

156

0.83

0.21

1.8

3.7

61.42

53.43

0.62

150

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

100

945

1.06

0.20

3.5

3.2

0.87

0.83

nmol/l

0.22

733

(4035726) Immunohistochemistry procedure

449

4383

1.03

0.20

1.4

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.20

0.0

1.1

—

6.13

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.20

0.0

4.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.20

0.0

1.0

—

(40768800) Prostate Pathology biopsy report

728

0.93

0.20

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

108

1.20

0.20

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

231

1.13

0.19

2.0

2.1

166.38

147.33

ug/min

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.18

0.19

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.18

0.19

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

726

0.94

0.19

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

154

0.84

0.19

1.8

1.7

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

132

0.83

0.18

1.6

1.4

25.33

33.57

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.21

0.18

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

425

0.92

0.18

1.3

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

185

1.14

0.18

2.0

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

185

1.14

0.18

2.0

1.8

—

(3024263) Appearance of Synovial fluid

268

0.90

0.17

1.6

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.72

0.16

2.6

7.1

—

(40758292) HTLV I+II Ab panel - Serum

0.71

0.16

1.2

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

165

1592

1.04

0.16

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

340

1.09

0.16

1.7

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.16

0.16

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

302

1.09

0.16

1.1

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

187

1.12

0.15

2.0

1.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.77

0.15

1.8

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

790

0.95

0.15

1.6

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

192

0.89

0.14

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

179

1.12

0.14

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

480

0.94

0.13

1.4

1.5

63821.62

78142.32

e6/l

0.18

277

(3017569) Oxygen content in Arterial blood

218

1.10

0.13

1.6

2.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

293

2871

1.02

0.12

3.0

3.5

33.60

56.22

u/ml

1.63

275

2763

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

153

1.11

0.11

1.1

1.2

83.29

90.40

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

105

1.14

0.11

1.5

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

144

1.11

0.10

1.4

1.2

40.46

37.95

g/l

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

156

0.90

0.10

1.2

1.3

—

(3045142) Bone marrow Pathology biopsy report

526

1.05

0.09

1.2

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

116

1.12

0.09

1.5

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

414

4087

1.01

0.09

1.8

1.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.11

0.09

1.2

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

134

0.90

0.08

1.0

—

(3044007) Cell count panel - Peritoneal fluid

134

0.90

0.08

3.4

2.0

—

(3018133) Calcium [Moles/volume] in Urine

1.09

0.08

2.7

2.1

3.52

2.81

mmol/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

123

0.89

0.08

1.2

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

156

1.09

0.08

1.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.06

0.08

1.0

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

166

1.08

0.07

1.7

2.0

—

(3034426) Prothrombin time (PT)

166

1.08

0.07

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

508

5130

0.99

0.07

3.3

4.0

5.75

30.31

ug/l

2.94

404

4116

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.08

0.07

1.1

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

184

0.92

0.07

1.5

1.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

108

1.11

0.07

1.2

144.26

389.11

ug/l

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.06

0.07

1.0

1.2

—

(3012441) Differential panel - Pleural fluid

448

0.96

0.07

1.4

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.12

0.06

2.6

3.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.89

0.06

1.0

1.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

224

0.94

0.06

2.3

3.2

—

(3045716) Anion gap in Serum or Plasma

226

1.06

0.06

1.3

2.3

9.41

9.64

mmol/l

0.10

221

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

266

1.05

0.06

1.4

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

294

0.95

0.06

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

129

1.09

0.05

4.6

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

120

1.08

0.04

1.1

1.8

3.37

2.10

ug/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

129

0.93

0.03

1.0

1.7

—

(3016750) Collection duration of Urine

260

1.04

0.03

1.9

2.2

474.05

496.58

min

0.50

191

(3000034) Microalbumin [Mass/volume] in Urine

441

0.97

0.03

2.9

3.1

17.50

37.01

mg/l

1.57

325

(3044242) Glucose [Moles/volume] in Arterial blood

231

1.04

0.02

1.5

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

142

1.06

0.02

2.0

3.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

142

1.06

0.02

2.0

3.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

640

0.98

0.02

1.4

1.3

7.09

7.33

mmol/l

0.28

570

(3014148) Varicella zoster virus Ab [Titer] in Serum

569

0.98

0.02

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

621

1.01

0.01

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

328

0.98

0.01

6.3

6.5

—

(3018572) Chloride [Moles/volume] in Blood

108

1090

0.99

0.01

5.9

7.4

104.71

105.16

mmol/l

0.49

969

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

368

0.98

0.01

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

153

1.05

0.01

1.1

87.33

90.01

—

(3039000) Anion gap in Blood

108

1089

0.99

0.01

5.9

7.4

10.44

11.27

mmol/l

2.21

968

(40768441) Liver Pathology biopsy report

363

1.02

0.01

1.5

1.4

—

(3022689) Creatine [Moles/volume] in Urine

134

1.04

0.00

1.1

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

174

1.03

0.00

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

162

0.99

0.00

1.1

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

165

0.97

0.00

2.1

2.2

263.38

799.31

e6/l

—

119

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

375

1.01

0.00

1.9

2.1

2.48

1.87

u/field

0.26

148

(3042733) HLA Ab [Presence] in Serum

136

1.03

0.00

5.6

5.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

404

0.99

0.00

1.1

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

696

1.01

0.00

1.2

1.1

116.28

117.71

0.12

623

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.89

-0.00

1.0

1.6

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(3001729) Color of Synovial fluid

1.00

-0.00

1.2

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.94

-0.00

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.98

-0.00

1.4

1.1

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

1.8

—

5.50

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

130

1.00

-0.00

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

0.91

-0.00

1.5

1.4

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

520

1.00

-0.00

2.4

2.3

1.19

1.31

g/24h

0.10

253

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

1.73

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

1.00

-0.00

1.4

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.40

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.2

—

40.14

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_RLS and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_RLS	1.061 [0.92, 1.23]	0.425
Birth year	0.993 [0.98, 1.0]	0.087

During the follow-up period (1.1.1998 — 31.12.2019), 1342 out of 10279 females with G6_RLS died.

Males

Parameter	HR [95% CI]	p-value
G6_RLS	1.246 [1.07, 1.45]	0.004
Birth year	0.988 [0.98, 1.0]	0.009

During the follow-up period (1.1.1998 — 31.12.2019), 1193 out of 6145 males with G6_RLS died.

Mortality risk

Mortality risk for people of age

years, who have G6_RLS.

N-year risk	Females	Males
1	0.061%	0.23%
5	0.57%	1.436%
10	1.463%	3.607%
15	2.728%	6.773%
20	4.931%	11.498%

Relationships between endpoints

↥

Index endpoint: G6_RLS – Restless leg syndrome

GWS hits: 14

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Restless leg syndrome

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints